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ABSTRACT 
Survival of Mycoplasma Species in Recycled Bedding Sand and Possible Implications for 
Disease Transmission to Ruminants 
by 
Anne E. Justice-Allen, Master of Science 
Utah State University, 2010 
Major Professor:  Dr. David Wilson 
Department:  Animal, Dairy and Veterinary Sciences 
Mycoplasmas are a group of bacteria which are small in size, lack a cell wall, and 
have small genomes in comparison to other bacteria.  The members of the group that are 
pathogenic utilize several mechanisms to evade the host’s immune system.  These 
processes affect surveillance and control mechanisms such as serologic testing and 
vaccination.  Many of these organisms cause diseases of livestock, which heavily impact 
production parameters such as weight gain, milk yield, and egg production.  
Mycoplasmas also cause disease in people.  
Mycoplasma spp. can cause mastitis, metritis, pneumonia, and arthritis.  The 
currently documented routes of transmission of Mycoplasma spp. are through fomites and 
by direct animal contact.  The existence of environmental sources for Mycoplasma spp. 
and their role in transmission are poorly characterized.  Mycoplasma spp. (confirmed as 
M. bovis using PCR) was found in recycled bedding sand from a dairy experiencing an 
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outbreak of mycoplasma mastitis.  The possibility of a persistent environmental source of 
Mycoplasma spp. in recycled bedding sand was further investigated using recycled sand 
from the dairy. Study objectives included determining factors associated with the 
persistence of Mycoplasma spp. in recycled bedding sand and the duration of survival of 
mycoplasmas in the sand. We also evaluated 2 disinfectants at 2 different concentrations 
each for the elimination of Mycoplasma spp. from contaminated sand.   
Mycoplasma spp. survived in the sand pile intermittently over a period of 8 
months.  The concentration of Mycoplasma spp. within the sand pile was directly related 
to temperature and precipitation.  The survival of Mycoplasma spp. at a greater than 
expected range of temperatures suggests the formation of a biofilm.  Ideal temperatures 
for replication of Mycoplasma spp. occurred between 15 °C and 20 °C. Moisture in the 
sand and movement of the sand pile also appeared to play a role in replication of 
mycoplasmas.  Sodium hypochlorite (0.5%) and chlorhexidine (2%) were efficacious in 
eliminating Mycoplasma spp. from contaminated bedding sand.  Recycled bedding sand 
could be an environmental source of Mycoplasma spp. infections, including M. bovis, in 
dairy cows.  Future studies should investigate the contribution of this environmental 
source to the epidemiology of mycoplasma infections in dairy cattle and other ruminants. 
(124 pages) 
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Disease is a state where normal physiological processes are disrupted in a part, 
organ, or system of an organism resulting in signs or symptoms.  Disease can be caused 
by many different mechanisms and agents, such as infection, genetic defect or 
environmental stress.  Bacteria can be both disease agents as well as participants in a 
host’s normal physiological processes.  Microbiologists and epidemiologists have 
become increasingly aware that just as with macroorganisms, microorganisms fit into 
ecological niches both within and outside of the host.  One current model describes 
disease as an interaction between the host, the environment, and the agent. 
This thesis describes the characteristics of one set of organisms, the mycoplasmas, 
and the mechanisms by which a number of them cause disease in man and animals.  
Characteristics of mycoplasmas that are important to consider in the investigation and 
management of disease outbreaks are the requirements for growth and laboratory 
isolation, the routes of transmission between animals, the methods available for 
identification of infected animals, and the value of vaccines, antibiotics, or management 
and husbandry practices for control.  The diseases caused by mycoplasmas are both acute 
and chronic, and many are important because of the impact of the infections on the 
productivity of livestock animals and birds.   
Because this group of organisms lacks a cell wall, environmental survival has 
been considered to be short and the primary routes of transmission have been described 
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as by direct contact between animals or by contaminated wet surfaces such as milking 
equipment (Jasper, 1977; Nagatomo et al., 2001; González and Wilson, 2003).  During an 
investigation into an outbreak of mastitis, Mycoplasma bovis was isolated from the 
infected dairy cows and from the sand which was used to bed their freestall housing.  
Evaluation of the bedding materials at several other mycoplasma-positive dairy farms 
found 2 additional farms also had M. bovis in the bedding.  This finding led to the 
development of the observational study of the survival of a mycoplasma species, 
confirmed as M. bovis by PCR, described in this thesis.  The results of this research could 
affect how mycoplasmal diseases, specifically mycoplasmal mastitis, are managed. 
REFERENCES 
González, R. N., and D. J. Wilson.  2003.  Mycoplasmal mastitis in dairy herds.  Vet. 
Clin. North Am. Food Anim. Prac. 19:199-221.  
Jasper, D. E.  1977.  Mycoplasma and mycoplasma mastitis.  J. Am. Vet. Med. Assoc. 
170:1167-72. 
Nagatomo, H., Y. Takegahara, T. Sonoda, A. Yamaguchi, R. Uemura, S. Hagiwara, and 
M. Sueyoshi.  2001.  Comparative studies of the persistence of animal mycoplasma under 
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CHAPTER 2 
LITERATURE REVIEW OF MYCOPLASMAS—PHYLOGENY, GROWTH 
REQUIREMENTS, DISEASES, AND PATHOGENESIS 
History and Phylogeny 
The term mycoplasma has been used to designate both members of a class of 
organisms Mollicutes as well as members of the genus Mycoplasma (Razin, 1978).  In this 
thesis, the term mycoplasma will refer only to those members of the genus.  The Mollicutes 
have been grouped together because of the common characteristics of a small genome  
(0.58 - 2.2 Mbp) with low guanine-cytosine content (a measure of DNA variability used to 
characterize prokaryotes) and an absent cell wall (Razin and Hermann, 2002).  The first 
mycoplasma organism was identified in 1896 by Nocard and Roux as the agent of bovine 
pleuropneumonia (Nocard et al., 1896).  Originally the organism was classified as a virus 
because it was filterable (passed through a Chamberland filter), could not be cultured using 
the solid agar media available, and could just be detected with the light microscopes in use 
at the time (Nocard et al., 1896; Eaton et al., 1945; Goodburn and Marmion, 1962; Harwick 
et al., 1972).  Because the organism was not readily visible, Koch’s postulates were not 
technically satisfied but the researchers were able to remove the organism from infected 
calves, grow it in semi-permeable, membranous pouches in the peritoneal cavities of 
rabbits, (without the rabbits becoming infected), inoculate a naïve calf with the culture, and 
cause the classic form of the disease (Nocard et al., 1896).  The second mycoplasma to be 
identified and isolated by inoculation of chick embryos with filtered (600 mµ collodion 
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membrane) sputum from human patients was M. pneumoniae (Eaton et al., 1945; Goodburn 
and Marmion, 1962; Harwick et al., 1972).  There are now approximately 200 validly 
described species in 8 genera (Table 2.1, Johansson and Peterson, 2002; International 
Committee on Systematics of Prokaryotics, 2003).  These organisms occur in insects, 
plants, plant surfaces, animals, bovine and ovine rumens, and people.  The Mollicutes have 
been placed in the phylum Firmicutes with the classes Bacilli and Clostridia based on 
rRNA sequence analysis (Maniloff, 2002).  This also reflects their evolutionary origin in 
the Late Proterozoic when the AAP (Acholeplasmataceae, Anaeroplasmataceae, and  
Table 2.1:  Classification of Mollicutes (adapted from Razin and International Committee 
on Systematics of Prokaryotics) 

































Anaeroplasma 4 rumen 
Anaeroplasmatales Anaeroplasmataceae 
Asteroplasma 1 rumen 
1
Candidate species in parentheses; from ICSP 
2
Includes 11 unnamed species 
3
Razin tentative classification; not in ICSP 
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Phytoplasma) branch diverged from the Streptococcus branch (Maniloff, 2002).  This 
divergence coincided with genome reduction and loss of the ability to produce a cell wall 
(Maniloff, 2002).  Two more divergences occurred in the Middle Ordovician and at the 
Silurian-Devonian boundary which resulted in the separation of the Mycoplasmataceae 
branch containing the genera Mycoplasma and Ureaplasma (Maniloff, 2002).  
Mycoplasmas evolved dramatically with the appearance of mammals and other vertebrates 
approximately 191 million years ago (Maniloff, 2002). 
With the advent of DNA sequencing methods, microorganisms are being 
reclassified based on similarities in the nucleotide sequence of all or part of the genome.  
Recently, 2 groups of previously identified red blood cell (RBC) parasites, formerly called 
Eperythrozoon spp. and Haemobartonella spp., have been moved from the Rickettsiales to 
Mycoplasmatales class Mollicutes.  Most microbiologists agree with this change because 
the similarity between the sequences of 2 gene segments, the 16s rRNA and the RNase P 
gene, of the former Eperythrozoon spp. and Haemobartonella spp. and M. pneumoniae is 
76% (Neimark et al., 2001; Tasker et al., 2003; Uilenberg et al., 2004).  Additional 
similarities between the hemoparasites and mycoplasmas are the absence of a cell wall, 
small size (0.3 to 0.5 µm), pleomorphic morphology, and the presence of attachment 
structures (Neimark et al., 2001).  Some microbiologists believe that the organisms should 
be placed in the Mycoplasma genus (Niemark et al., 2001).  Others indicate that because 
the reclassified group attaches only to RBC (some appear free in the plasma), and the 
similarity is less than the similarity that occurs between other closely related genera, such a 
reclassification is inappropriate (Uilenberg et al., 2004). 
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Physiology and Growth Requirements 
As a group, the mycoplasmas have lost, through genome reduction, many 
synthetic and physiological biochemical pathways.  Acholeplasma laidlawii, M. hominis, 
and M. mycoides ssp. mycoides lack the ability to synthesize de novo purine and 
pyrimidine bases (Razin, 1978).   In contrast, M. mycoides ssp. mycoides does have the 
capacity to synthesize all of the nucleotides, including adenosine triphosphate and 
cytosine triphosphate from the nucleosides guanine, uracil, and thymine (Razin, 1978).  
Analysis of the genomes for M. genitalium, M. pneumoniae, and U. urealyticum found no 
genes coding for amino acid metabolism and a small number of genes for lipid 
metabolism and energy metabolism when compared to bacteria such as Escherichia coli 
and Bacillus subtilis (Pollack, 2002).  There are 3 pathways utilized by mycoplasmas for 
energy production:  fermentation of sugars to lactate, oxidation of lactate or pyruvate, and 
the metabolism of L-arginine to ornithine (Keçeli and Miles, 2002).  There is significant 
variation among the mycoplasma species, with some having the mechanisms for all 3 
metabolic pathways and some having only 1 route of energy generation.   The Embden-
Meyerhoff-Parnas pathway is present to some degree in all of the Mollicutes studied to 
date and is believed to be the primary method of ATP generation for the group (Pollack et 
al., 1997).  Ureaplasma is unique in the group because of its ability to hydrolyze urea 
(Razin, 1978).  All of the various physiological pathways have not been identified for all 
mycoplasma species.  The number of genes for transcription and translation are 
comparable to those of other bacteria (Pollack, 2002). 
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The result of the reduction in the physiologic capacities of mycoplasmas is the 
requirement for complex media when attempting to isolate or culture the organisms.  The 
first microbial cultures with formulated media were accomplished in the 1930’s by 
Ledingham and Gey working separately using media enriched with serum or human 
placental cord blood (Morton et al., 1952; Harwick et al., 1972).  The identification by 
Klieneberger in 1935 of classical mycoplasma colonies contaminating a culture of 
Streptobacillus moniliformis as “L forms” led to years of confusion between bacterial 
variants lacking cell walls and Mycoplasma spp. (Morton et al., 1952).  The confusion 
began to be resolved in 1961 when Liu demonstrated that the agent of atypical 
pneumonia was particulate (Harwick et al., 1972).  Shortly thereafter, the organism was 
cultured on solid media and named Mycoplasma pneumoniae (Chanock et al., 1962).  The 
researchers determined that both horse serum and yeast extract were required for growth 
of the organism.  Since then many media have been developed for the isolation of 
mycoplasmas from animal tissues and fluids (Table 2.2). 
The most basic and earliest medium used for mycoplasma culture consists of 50 g 
dehydrated beef heart, 10 g peptone, 5 g NaCl, and 14 g agar per liter of distilled water 
(Morton et al., 1952; Hayflick and Chanock, 1965).  By 1951, this product was available 
commercially and a number of researchers were experimenting with additional 
supplementation in order to increase the isolation of various Mycoplasma spp. (Morton et 
al., 1952; Chanock et al., 1962; Barber and Fabricant, 1962; Hayflick and Chanock, 
1965).  One of the media developed by Chanock et al. (1962), Hayflick’s medium, is still 
used, with the modification of the addition of various antibiotics, for the isolation of 
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Table 2.2:  Media used for isolation of mycoplasmas 
 
Component Hayflick’s Friis’ L'Ecuyer’s SP4 
Broth Difco PPLO
1
 PPLO and BHI
2











of gelatin, fetal 
bovine serum 






 dextran   






Other    CMRL 1066
5 
1
PPLO = Pleuropneumonia-like organism media  
2
BHI = Brain heart infusion  
3
Yeastolate = the water soluble portion of autolyzed yeast 
4
DEAE = diethylamino ethanol 
5
CMRL 1066 = Connaught Medical Research Laboratories 1066, a defined medium 
consisting of amino acids, nucleic acids, and vitamins.  An example of 1 commercial type 
is available from Sigma (http://www.sigmaaldrich.com/united-states.html). 
Mycoplasma spp. (Table 2.2).  Other media which are in common use are Friis’ and SP4 
(Table 2.2).  It has become common practice to modify these media with the addition of 
various antibiotics such as thallium acetate, penicillin, ampicillin, polymyxin B, and 
kanamycin (Barber and Fabricant, 1962; L’Ecuyer, 1969; Harwick et al., 1972; Ciprián et 
al., 1988). 
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Mycoplasmas and Disease in Animals and Man 
The impetus for the development of media to isolate mycoplasma organisms was 
the realization that there was a group of microorganisms causing serious diseases in 
animals and man which was smaller than other bacteria and not a virus.  Nocard et al. 
were working to discover the agent of contagious bovine pleuropneumonia, a devastating 
disease of cattle which still has a significant economic impact in southern and eastern 
Africa (Thiaucourt et al., 2004).  The first pathologic mycoplasma organism discovered 
to cause disease in man, M. hominis, was isolated from a Bartholin’s gland abscess in 
1937 (Morton et al., 1952; Harwick et al., 1972; Bébéar, 2002).  This was followed by the 
identification in 1944 of M. pneumoniae as the cause of Primary Atypical Pneumonia 
(PAP) which was initially called Eaton’s agent and thought to be a virus (Eaton et al., 
1945; Harwick et al., 1972).  By 1965, pathogenic mycoplasmas had been identified in 15 
different animals (Hayflick and Chanock, 1965).  Previously unrecognized species of 
mycoplasma have been identified in the past 10 years in part due to the development of 
molecular and DNA based methods such as PCR (Kirchhoff et al., 1997; Helmick et al., 
2002; Hammond et al., 2003; Haulena et al., 2006).  Table 2.3 lists the currently 
recognized important pathogenic mycoplasmas of animals and man as well as the clinical 
syndromes caused by each.  The pathogenesis, epidemiology, and treatment of some of 
the more important mycoplasmal diseases of animals and man are reviewed. 
Mycoplasma pneumoniae.  
 Of the 6 mycoplasmas associated with disease in man, M. pneumoniae is the 
most thoroughly studied and the most important (Waites and Talkington, 2004; Vervolet 
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et al., 2007).  It was first cultured in 1944 but thought to be a virus because it was 
filterable and was not susceptible to penicillin (Eaton et al., 1945).  In1961, Goodburn  
Table 2.3:  Major pathogens of animals and man grouped by host species 
 
Host Agent Disease 
Human M. pneumoniae Primary atypical pneumonia 
Human M. hominis 
Salpingitis, pyelonephritis, 
pelvic inflammatory disease 
Human U. urealyticum Urethritis 
Cattle M. mycoides ssp. mycoides Pleuropneumonia 
Cattle/bison/deer M. bovis Mastitis 
Cattle M. californicum Mastitis 
Cattle M. canadense Mastitis 
Cattle/bighorn sheep M. arginini Mastitis 
Cattle/bison M. bovigenitalium Infertility, mastitis 
Cattle M. dispar Calf pneumonia 
Goats 





M. capricolum ssp. 
capripneumoniae 
Pleuropneumonia 
Goats/sheep M. agalactiae Mastitis 
Sheep/deer M. conjunctivae Keratoconjunctivitis 
Sheep/bighorn sheep M. ovipneumoniae Pneumonia 
Horses M. felis Pleuritis 
Swine M. hyopneumoniae Pneumonia 
Swine M. hyorhinis Arthritis, pneumonia 
Swine M. hyosynoviae Arthritis 
Mice/rats M. pulmonis Respiratory disease 
Mice/rats M. arthritidis Arthritis 
Turkeys/chickens M. gallisepticum 
Sinusitis, respiratory 
disease 
Turkeys M. meleagridis 
Air sacculitis, embryo 
mortality 
Turkeys/chickens M. iowae Embryo mortality, arthritis 
Turkeys/chickens M. synoviae Synovitis 
Passerine birds M. gallisepticum Conjunctivitis 
Tortoises M. agassizii Sinusitis, conjunctivitis 
Crocodiles M. crocodyli Arthritis 
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and Marmion observed the organism as a small coccobacillus on the mucous layer of 
bronchial epithelium and found that it was susceptible to tetracycline and erythromycin 
(Goodburn and Marmion, 1962).  At about the same time, the organism was successfully 
cultured on a solid medium (Chanock et al., 1962).  At present, the entire genome has 
been sequenced, the mechanisms of adhesion to the host cell have been elaborated, and 
several modes of pathogenesis and immune system modulation have been described 
(Waites and Talkington, 2004). 
First described as the agent for PAP, M. pneumoniae causes a broad range of 
clinical manifestations in humans.  The usual incubation period ranges from 1 to 3 weeks 
(Waites and Talkington, 2004; Vervolet et al., 2007).  The earliest symptoms are non-
specific and consist of fever, sore throat, hoarseness, headache, chills, myalgia, and 
earache (Waites and Talkington, 2004; Vervolet et al., 2007).  A harsh, persistent, non-
productive cough is a classic sign but it is not pathognomonic (Waites and Talkington, 
2004; Vervolet et al., 2007).  Mycoplasma pneumoniae has been determined to be the 
cause of 15% to 20% of the reported pneumonias (Waites and Talkington, 2004); 
pneumonia occurs in 3% to10% of the cases that begin with milder symptoms (Vervolet 
et al., 2007).  Extra-pulmonary pathology occurs in 25% of infected patients (Waites and 
Talkington, 2004).  The organism has been cultured from joints, cerebrospinal fluid, and 
the pericardium (Waites and Talkington, 2004).  The most common extra-pulmonary 
complications are dermatological and consist of maculopapular and vesicular rashes, 
conjunctivitis, erythema multiforme, and ulcerative stomatitis (Waites and Talkington, 
2004).  Non-specific arthralgias, myalgias, and septic arthritis occur in 14% of patients 
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(Waites and Talkington, 2004).  Less common sequelae are encephalitis, meningitis, 
polyradiculitis, pericarditis, myocarditis, hemolytic anemia, disseminated intravascular 
coagulation, acute glomerulonephritis, otitis externa, and otitis media (Waites and 
Talkington, 2004).  Many of the extra-pulmonary disease syndromes have an 
immunologic component which is a result of the interaction of M. pneumoniae with 
immune cells and the production of various cytokines.  This will be discussed further in 
the section on mycoplasmas and the immune system. 
Disease occurs most frequently in children from 5 to 15 years of age, and young 
adults that are housed in group settings such as college dormitories, military barracks, 
and prisons (Waites and Talkington, 2004; Vervolet et al., 2007).  Several studies have 
found that epidemics occur every 3 to 5 years (Jacobs, 2002; Waites and Talkington, 
2004).  Genetic research has determined that there are 8 subtypes of M. pneumoniae 
divided into 2 major groups based on variations in the P1 adhesin gene (Jacobs, 2002; 
Waites and Talkington, 2004).  Epidemiologic studies have found that when an epidemic 
occurs, the causative subtype isolated is different than the 1 that had caused the most 
recent previous outbreak (Jacobs, 2002; Waites and Talkington, 2004).  In 51% of cases, 
M. pneumoniae occurs in a co-infection with viruses and other bacteria and there is 
evidence that it intensifies the severity of viral infections (Waites and Talkington, 2004; 
Vervolet et al., 2007). 
Mycoplasma pneumoniae causes disease through several different mechanisms.  
The first step in the process is binding to the host cell by means of several adhesin 
proteins which appear to attach to host sialoglyco-conjugates and sulfated glycolipids 
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(Waites and Talkington, 2004; Vervolet et al., 2007).  The organism produces hydrogen 
peroxide hydroxy radicals, and superoxide anions which damage the ciliated cells of 
respiratory epithelium (Waites and Talkington, 2004; Vervolet et al., 2007).  Mycoplasma 
pneumoniae also activates the complement system causing the production of tumor 
necrosis factor α (TNF-α), interferon γ (IFN-γ), interleukin 1β (IL-1β), interleukin 6 (IL-
6), and interleukin 8 (IL-8), an immune response consisting of both type 1 and type 2 
cytokines (Waites and Talkington, 2004; Vervolet et al., 2007).  These factors can be 
effective in eliminating the infection but can also exacerbate underlying chronic diseases 
such as asthma, and chronic obstructive pulmonary disease (COPD; Waites and 
Talkington, 2004; Vervolet et al., 2007).  Pathologic changes consist of ulceration of 
airway epithelium, edema of the bronchi and bronchioles, cellular (neutrophils, 
lymphocytes, plasma cells, and macrophages) infiltrates of the bronchioles and alveoli, 
Type II pneumocyte hyperplasia, pleural effusions and in more severe cases, lung 
abscesses and pulmonary fibrosis (Waites and Talkington, 2004). 
Due to fastidious culture requirements and the slow growth profile (21 days), 
diagnosis of M. pneumoniae by culture is difficult.  Definitive species identification of 
positive cultures requires species specific anti-sera (Mahon et al., 2007).  While there is 
an enzyme-linked immunosorbent assay (ELISA) available, its limit of detection is very 
near the typical number of organisms in a sputum sample which means that there are a 
number of false negatives resulting in a low sensitivity for the test (Waites and 
Talkington, 2004; Vervolet et al., 2007).  Numerous PCR techniques have been 
developed and used but results vary with the specific methods and primers used (Waites 
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and Talkington, 2004).  Polymerase chain reaction will likely become the diagnostic 
method of choice when a method is perfected.  At present, the diagnosis is usually made 
with serologic methods.  Complement fixation (CF), indirect immunofluorescent 
antibody, particle agglutination, and ELISA have all been used (Waites and Talkington, 
2004; Vervolet et al., 2007).  Enzyme-linked immunosorbent assay and particle 
agglutination detect IgM and IgG antibodies to M. pneumoniae (Waites and Talkington, 
2004; Vervolet et al., 2007).  The ELISA tests are the most widely used method for 
diagnosing M. pneumoniae infection but like all serologic tests, they are limited by the 
requirement for testing of acute and convalescent samples (Waites and Talkington, 2004; 
Vervolet et al., 2007). 
Mycoplasma pneumoniae infection usually responds to treatment with macrolides, 
ketolides (a subset of macrolides), tetracyclines, and fluoroquinolones and treatment 
failures have rarely been reported (Waites and Talkington, 2004; Vervolet et al., 2007).  
Minimum Inhibitory Concentration (MIC) testing is generally considered unnecessary 
because there is little variability for in vitro results and very few antibiotic resistant M. 
pneumoniae organisms have been documented (Waites and Talkington, 2004).  
Mycoplasma pneumoniae is also susceptible to chloramphenicol, aminoglycosides, and 
streptogramins however these are seldom used due to the potential for side-effects 
(Waites and Talkington, 2004).  Erythromycin has been the antibiotic of choice especially 
for children, however it is being supplanted by the newer macrolides such as 
azithromycin and clarithromycin because they are tolerated better and have once or twice 
a day dosing while erythromycin must be administered every 6 hours (Waites and 
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Talkington, 2004; Vervolet et al., 2007).  For adults, the newer fluoroquinolones are often 
the preferred treatment because they are effective against a number of respiratory 
pathogens (Waites and Talkington, 2004). 
Mycoplasma mycoides ssp. mycoides    
Contagious bovine pleuropneumonia (CBPP) is a highly contagious and 
economically important disease of cattle caused by Mycoplasma mycoides ssp. mycoides 
Small Colony (SC) and was first described by Gallo in 1564 (Thiaucourt et al., 2004).  It 
has occurred in every region of the world with cattle except Madagascar and South 
America; however it has been eradicated from North America, most of Europe, and 
Australia (Thiaucourt et al., 2004).  It was the first mycoplasma for which Koch’s 
postulates were satisfied and to be grown on artificial media (Nocard et al., 1896). 
It causes disease in domestic cattle species (Bos taurus, B. indicus) and water 
buffalo (B. bubalis; OIE, 2009a).  The course of the infection may be peracute, acute, 
subacute, or chronic.  Acute signs consist of fever, purulent to mucopurulent nasal 
charge, a soft moist cough, and occasionally epistaxis.  As the disease progresses, the 
animals become reluctant to move, and stand with outstretched necks.  Calves may also 
have septic arthritis.  With subacute infections, the signs are basically the same but 
milder.  Animals that are chronically infected have recurrent low grade fevers, a loss of 
body condition, and will exhibit respiratory signs with exertion (Thiaucourt et al., 2004). 
Contagious bovine pleuropneumonia is transmitted by respiratory droplets from 
infected animals.  Respiratory secretions, urine, and uterine discharges can be infectious 
(Thiaucourt et al., 2004).  There is some evidence for transfer of disease through 
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contaminated feed (Windsor and Masiga, 1977).  The organism can survive in the 
environment for 3 days in the tropics and 2 weeks in temperate climates (Thiaucourt et 
al., 2004).  The incubation period is usually between 3 and 6 weeks but can be as long as 
6 months (Thiaucourt et al., 2004; OIE, 2009a).  The long incubation period causes 
outbreaks to intensify slowly.  As the number of organisms in the environment and 
infected animals increase, those animals that are still susceptible experience severe acute 
and peracute disease (Thiaucourt et al., 2004).  Antibiotic treatment is not recommended 
either for the individual animal or as a means to control an epidemic because of poor 
clinical response and cure rates (Thiaucourt et al., 2004).   
As with M. pneumoniae in man, M. mycoides ssp. mycoides SC infection begins 
with the organism adhering to the respiratory epithelium (Thiaucourt et al., 2004).  The 
signs of the disease are caused by severe bronchiolitis, bronchopneumonia, and fibrinous 
pleuritis.  Interlobular lung septa are widened with fluid or fibrous tissue (Kahn and Line, 
2005).  Microscopically, there is a severe fibrinous pneumonia, fibrinous pleurisy, 
thrombosis, and areas of necrosis (Kahn and Line, 2005).  Sequestra form when necrotic 
tissue becomes encapsulated by a fibrous layer up to 1 cm thick (Thiaucourt et al., 2004).  
On a molecular level, only a few of the cytotoxic compounds and processes have been 
determined.  Strains of M. mycoides ssp. mycoides SC that are more virulent produce 
more hydrogen peroxide through a metabolic pathway that utilizes glycerol (Pilo et al., 
2007).  A polysaccharide galactan, 6-O-β-D-galactofuranosyl-D-galactose, has also been 
found to contribute to the virulence of the organism perhaps because it is similar to 
galactans in the lungs of cattle (Thiacourt et al., 2004; Pilo et al., 2007).  Much of the 
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research into the effects of M. mycoides ssp. mycoides SC has been directed at production 
of an effective vaccine rather than characterizing the cytokines produced during the 
immune response (Dedieu et al., 2006; Totté et al., 2007).  Infection with M. mycoides 
ssp. mycoides SC is known to cause a marked inflammatory reaction and TNF-α is 
thought to play a role (Thiacourt et al., 2004). 
Definitive diagnosis of CBPP is easier now than when Nocard et al. were using 
membranous pouches implanted in rabbits (Nocard et al., 1896; Thiacourt et al., 2004).  
The organism can be cultured in 2 to 3 days from aseptically collected pleural fluid from 
an animal not previously treated with antibiotics (Thiacourt et al., 2004).  As with other 
mycoplasmas, specific identification is accomplished with biochemical tests, growth 
inhibition by hyperimmune serum, or PCR (Thiacourt et al., 2004).  In addition, the 
organism can be detected using an agar-gel precipitation test directed at galactan 
(Thiacourt et al., 2004).  A CF test and a competitive ELISA test have been recognized 
by the World Animal Health Organization (OIE) as valid for serological diagnosis of 
herds infected with CBPP (Thiacourt et al., 2004; Gonçalves et al., 2008; OIE, 2009a).  
Neither test detects vaccine induced antibodies so they can be used to measure the 
prevalence of naturally acquired infections (Thiacourt et al., 2004).  However both have 
sensitivities that are less than 80% which means that disease rates are underestimated and 
low levels of disease will not be detected (Gonçalves et al., 2008).  An immunoblot test 
was developed in Portugal in1996 and a study comparing it to the OIE approved CF test 
found that the CF test was also detecting M. bovis antibodies in addition to those against 
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M. mycoides ssp. mycoides which resulted in an overestimation of prevalence (Gonçalves 
et al., 2008). 
The importance of CBPP to the local and national economies of the regions 
affected by it has directed the methods used to control or eliminate it.  In most 
circumstances, emphasis is placed on eliminating it from or controlling it in a herd as 
opposed to treating the individual animal.  Control methods consist of culling affected 
herds, vaccination, restriction of animal movement, and quarantine.  Serologic testing is 
used in regions that border endemic areas.  Importation of animals from positive 
countries into those free of CBPP is also prohibited (Thiacourt et al., 2004). 
Mycoides Cluster Species of Sheep and Goats   
Four species of mycoplasmas in the mycoides group cause disease in sheep and 
goats.  Because these organisms are closely related genetically and immunogenically, it 
has been difficult until recently to clearly identify the organism causing each syndrome 
and accurately describe the diseases (Lefèvre and Thiacourt, 2004).  Three organisms in 
the mycoides cluster, M. mycoides ssp. mycoides LC (large colony), M. mycoides ssp. 
capri, and M. capricolum ssp. capricolum and 2 other mycoplasmas, M. putrefascens and 
M. agalactiae, have been grouped together based on the clinical syndrome of mastitis, 
arthritis, keratitis, pneumonia, and septicemia (MAKePS) caused with infection 
(Thiacourt and Bölske, 1996).  Some of the basic characteristics that differentiate the 
members of the mycoides cluster are listed in Table 2.4.  Economically and 
pathologically, the 2 most important members of this group of organisms are M. 
mycoides ssp. mycoides LC and M. capricolum ssp. capripneumoniae (DaMassa et al., 
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1992; Lefèvre and Thiacourt, 2004; Walker, 2004).  Originally identified as F38, M. 
capricolum ssp. capripneumoniae was given a definitive name in 1992 and determined to 
be the causative agent of contagious caprine pleuropneumonia (CCPP, DaMassa et al., 
1992; Lefèvre and Thiacourt, 2004; Walker, 2004). 
Table 2.4:  Mycoplasma mycoides and M. capricolum subgroup species affecting goats 
and sheep as primary hosts and differential qualities 
 
Quality M. mycoides subgroup M. capricolum subgroup 
Ssp. mycoides LC1
 
capri capricolum capripneumoniae 
Host goats, sheep, cattle goats goats, sheep, cattle goats 



























LC = Large Colony 
Contagious caprine pleuropneumonia is similar in many ways to CBPP.  A high 
fever occurs at the onset of clinical disease which is followed by coughing, respiratory 
distress, painful respiration, and a reluctance to move.  Morbidity can reach 100%, and 
mortality may be as high as 70% (Lefèvre and Thiacourt, 2004).  In endemic regions 
some animals experience a subacute form with similar but less intense signs.  The disease 
is transmitted by aerosol and requires close contact because the organism does not 
survive in the environment (Lefèvre and Thiacourt, 2004).  The incubation period is 
generally between 6 and 10 days (Lefèvre and Thiacourt, 2004) but the OIE International 
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Animal Health code chapter 14.4 sets the incubation period at 45 days (OIE, 2009b).  The 
disease occurs in northern, eastern, and central Africa, and the Arabian Peninsula and 
Turkey in the Middle East (Lefèvre and Thiacourt, 2004). 
Mycoplasma capricolum ssp. capripneumoniae causes a fibrinous 
pleuropneumonia which usually affects 1 lung but can also be lobar.  Serofibrinous 
pleuritis causes the accumulation of large quantities of serous or serosanguinous pleural 
fluid.  Abscessation of the lungs may occur.  There is no widening of the interlobular 
septa.  The lesions are restricted to the thoracic cavity.  Diagnosis of CCPP is difficult 
because other species of mycoplasmas and pasteurellas cause similar lesions (Thiacourt 
and Bölske, 1996; Lefèvre and Thiacourt, 2004).  Differentiation can be made based on 
the distribution of lesions because M. capricolum ssp. capripneumoniae only causes 
pleuropneumonia (Thiacourt and Bölske, 1996; Lefèvre and Thiacourt, 2004).  The 
organism can be cultured with some difficulty from pleural fluid and lung tissue, and 
metabolic or immunologic based tests are required for speciation.  One of the common 
methods of speciation, inhibition of growth by antiserum, has reduced specificity because 
M. capricolum ssp. capripneumoniae shares antigens with M. capricolum ssp. capricolum 
and Mycoplasma sp. group 7 (Thiacourt and Bölske, 1996; Lefèvre and Thiacourt, 2004). 
Recently, PCR methods have been developed to detect organisms in tissues but even 
these protocols require additional steps to improve speciation such as endonuclease 
digestion; identification is based on the number of fragments generated from the PCR 
product (Thiacourt and Bölske, 1996; Lefèvre and Thiacourt, 2004).   
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The serological tests available for herd-level testing for CCPP are a CF test, 
passive hemagglutination inhibition (HI), latex agglutination (LAT), and an indirect 
ELISA.  None of these tests have been rigorously validated with regards to specificity or 
sensitivity (Thiacourt and Bölske, 1996; Lefèvre and Thiacourt, 2004).  Part of the 
problem lays with the many shared antigens among the mycoplasma species.  For 
example, in an outbreak of CCPP reported in 1989, more goats were seropositive for M. 
mycoides ssp. capri than for M. capricolum ssp. capripneumoniae, the only organism 
isolated from diseased lungs (Thiacourt and Bölske, 1996).  As with CBPP, CF is the test 
recognized by the OIE.  A blocking-ELISA based on a monoclonal antibody (MAb) is 
more specific and does not cross-react with Mycoplasma sp. group 7 (Thiacourt et al., 
1994).   When the MAb is used for the detection of antigen in pleural fluid, the limit of 
detection is 10
7
 cfu/ml, a level that occurs in acutely infected animals (Thiacourt et al., 
1994). When used in a microtiter plate format, the blocking-ELISA facilitates the testing 
of large numbers of samples in a timely and economic manner (Thiacourt et al., 1994; 
Thiacourt et al., 1996).   
Animals respond best to early treatment with tetracyclines, macrolides or 
fluoroquinolones but treatment failures with disease recurrence are common; therefore 
some experts have recommended measures that include strict control on animal 
movement to prevent the introduction of the disease into a region and rapid institution of 
a herd-level test and slaughter protocol when the disease occurs in a new area (Thiacourt 
et al., 1996).  Use of an inactivated vaccine with a saponin adjuvant has been shown to 
create antibodies detectable for a year by CF and greater than a year by competitive 
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ELISA, and to result in both reduced mortality and morbidity (Thiacourt et al., 1996).  It 
is not known if antibody levels directly correspond to the level of protection provided for 
this disease.  A modified-live vaccine is being assessed and if proven effective would 
reduce the cost of immunization (Thiacourt et al., 1996). 
Mycoplasma mycoides ssp. mycoides LC and M. mycoides ssp. capri are 99% 
identical genetically and while there are serologic differences, they will very likely be 
combined into the same subspecies (Nicholas et al., 2008).  In contrast to M. capricolum 
ssp. capripneumoniae, M. mycoides ssp. capri causes septicemia, polyarthritis, 
pericarditis, peritonitis, lymphadenitis, mastitis and conjunctivitis in addition to fever and 
interstitial fibrinous pneumonia with widened and pale intralobular septa (DaMassa et al., 
1992; Nicholas et al., 2008).  The distribution of disease is worldwide but there is 
considerable geographic strain variation with the strains from Africa being less likely to 
cause mastitis and arthritis (DaMassa et al., 1992).  Mycoplasma mycoides ssp. capri is 
the most frequently reported caprine mycoplasma in the United States (Nicholas et al., 
2008).  Mycoplasma mycoides ssp. capri can be transmitted orally as well as by 
respiratory secretions in contrast to M. capricolum ssp. capripneumoniae which is only 
transmitted by respiratory secretions (DaMassa et al., 1992).  The growth characteristics 
and colony morphology make it easier to diagnose M. mycoides ssp. capri but additional 
metabolic and immunogenic tests are also used (DaMassa et al., 1992; Nicholas et al., 
2008).  Serologic testing using CF requires an array of antigens due to the similarities 
between the organisms of the mycoides cluster (DaMassa et al., 1992; Thiaucourt and 
Bölske, 1997).  In Europe it is important to distinguish M. mycoides ssp. capri from M. 
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capricolum ssp. capripneumoniae as the occurrence of the latter would be the result of a 
transborder disease incursion (Nicholas et al., 2008).  
Mycoplasma hyopneumoniae   
The cause of enzootic pneumonia of swine was determined in 1965 (Kobisch and 
Friis, 1996; Wallgren, 2004).  This disease is insidious and chronic and as a result the 
impact is primarily economic (Wallgren, 2004).  Like many of the mycoplasmas that 
cause pneumonia, infection begins with inhalation of the organism and subsequent 
adhesion to the respiratory epithelium at the apex of the cilia (Kobisch and Friis, 1996; 
Wallgren, 2004).  When it is the only infectious agent, M. hyopneumoniae causes high 
morbidity and low mortality with a dry cough which increases in intensity with exercise 
(Wallgren, 2004).  A decrease in appetite leads to slowed weight gain which is important 
because the disease is most prevalent in growing pigs (Kobisch and Friis, 1996; 
Wallgren, 2004).  In uncomplicated cases the infection resolves in 10 to 12 weeks, 
however, secondary infections are common (Wallgren, 2004).    Co-infection by M. 
hyopneumoniae and Pasteurella multocida is more severe than infection by M. 
hyopneumoniae alone (Ciprián et al., 1988; Kobisch and Friis, 1996). The lesions occur 
most commonly in the ventral regions of the accessory and middle lung lobes and consist 
of alveolar interstitial thickening due to marked infiltration by inflammatory cells, giant 
cell proliferation, and perivascular lymphoid hyperplasia (Wallgren, 2004).     
Diagnosis of M. hyopneumoniae with culture is complicated by slow growth 
characteristics and the occurrence of M. hyorhinis (nasal secretions) and M. hyosynoviae 
(infected tonsils) in the respiratory tract of swine (Kobisch and Friis, 1996; Wallgren, 
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2004).  Mycoplasma hyorhinis and M. hyosynoviae both cause polyarthritis (Kobisch and 
Friis, 1996).  Immunofluorescence and PCR are both more efficient methods than culture 
for identifying M. hyopneumoniae in tissues (Wallgren, 2004).  Serology is efficient at 
detecting the presence of disease in herds because the antibody response is detectable for 
as long as 20 weeks (Kobisch and Fris, 1996).  Indirect ELISA has become the preferred 
method of testing (Kobisch and Fris, 1996; Wallgren, 2004).  Control methods for M. 
hyopneumoniae have consisted of antibiotics (tetracyclines, macrolides, and some 
fluoroquinolones) in the face of outbreaks, especially for naïve herds, but long term use 
leads to the development of resistance (Kobisch and Friis, 1996; Wallgren, 2004).  
Management methods such as age segregated housing, closed herds, suitable stocking 
densities, proper ventilation, and vaccination are effective at controlling M. 
hyopneumoniae as well as M. hyorhinis and M. hyosynoviae (Kobisch and Friis, 1996; 
Wallgren, 2004).  Inactivated, whole-cell vaccines (bacterins) are widely available and in 
some countries are used in greater than 70% of herds (Maes et al., 2008).  A random 
sample survey of swine producers in the United States found that as of 2006, one third of 
the producers were immunizing against M. hyopneumoniae (USDA, 2008).  Vaccination 
strategies include immunizing piglets at 1 to 2 weeks of age, piglets at weaning, and sows 
and gilts while pregnant.  Vaccination increases weight gain and reduces mortality but 
protection is often incomplete (Kobisch and Friis, 1996; Maes et al., 2008).  Researchers 
are continuing to investigate innovative delivery routes, and subunit and DNA derived 
vaccines.  A plasma membrane derived vaccine has been tested and shown to provide 
protection to the piglets of vaccinated sows (Kobisch et al., 1987). 
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Mycoplasma gallisepticum    
Like M. hyopneumoniae in swine, losses in poultry due to M. gallisepticum are 
primarily economic because the disease caused by the organism is generally chronic and 
results in reduced production (Walker, 2004; Bradbury, 2005; Gaunson et al., 2006).  Of 
the mycoplasmas that infect birds, M. gallisepticum has been studied the most and the 
genome has been completely sequenced (Bradbury, 2005).  The clinical syndrome is 
primarily pulmonary with coughing and respiratory distress in chickens and sinusitis in 
turkeys but decreases in egg production can occur in both species (Walker, 2004; 
Bradbury, 2005).  The organism binds to respiratory epithelium with a specialized 
adhesion structure and the prokaryotic surface proteins GapA and CrmA (Bradbury, 
2005).  Other molecules that may play roles both as adhesins and in evading host immune 
defenses by antigenic variation include the lipoprotein VlhA (formerly known as pMGA) 
and the membrane protein PvpA (Bradbury, 2005).  Mycoplasma gallisepticum has the 
ability to penetrate non-phagocytic cells, another method for evading the host immune 
system (Bradbury, 2005; Kleven, 2008). 
The disease is transmitted via respiratory secretions as with other mycoplasmas.  
Mycoplasma gallisepticum is also transmitted to the embryo via infected semen or in egg 
development (Bradbury, 2005).  Like several of the other pathogenic mycoplasmas, M. 
gallisepticum has been found to act synergistically with another pathogen, E. coli in this 
case, resulting in increased pathology (Bradbury, 2005).  Microscopically, there is 
mononuclear infiltration of the respiratory epithelium, and hyperplasia of the mucous 
glands (Bradbury, 2005).  The immune response, especially the actions of T lymphocytes, 
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appears to have a role in the development of pathology (Gaunson et al., 2006).  
Resolution of clinical disease corresponds to the development of lymphoid follicles with 
B cells dominating the population and a proportional decline in T lymphocytes (Gaunson 
et al., 2006).   
Because of the impact on production, several countries have attempted to 
eliminate M. gallisepticum from their flocks and there has been some success.  The 
programs have utilized active surveillance, strategic use of antibiotics (tetracyclines, 
macrolides, quinolones, and tiamulin), and management practices.  The development of 
serum plate agglutination and ELISA tests allows for the rapid screening of large 
numbers of serum samples for antibodies (Kleven, 2008).  Hemagglutination inhibition 
tests or PCR are used for confirmation of positive screening test results because non-
specific serum agglutination or ELISA reactions due to recent vaccination or exposure to 
other mycoplasmas occur regularly (Kleven, 2008).  Reactions to vaccination induced 
antibodies are greatly reduced with purified antigens and species specific proteins 
(Stipkovits and Kempf, 1996).  A blocking ELISA test that uses a MAb against 1 of the 
more stable M. gallisepticum proteins can be used to test sera or eggs of any host species 
(Stipkovits and Kempf, 1996).  Dipping eggs in or injecting them with tylosin (a 
macrolide) or tetracycline is effective at eliminating vertical transmission (Stepkovits and 
Kempf, 1996; Kleven, 2008).  While antibiotics can help to minimize losses in the face of 
an outbreak, continual use is not advised and may lead to the development of resistance.  
Management techniques such as keeping breeder flocks small, maintaining good 
biosecurity, and minimizing the introduction of young males appear to be more effective 
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at controlling disease.   Vaccination is generally only employed when keeping the flock 
free of M. gallisepticum by other methods is not possible.  Bacterins have been available 
for more than 40 years but provide minimal protection from the disease and economic 
losses (Kleven, 2008).  There are 3 attenuated strains that have been tested for use in 
layers and breeding stock with varying levels of residual virulence, immunity, or adverse 
vaccination reactions (Whithear, 1996; Kleven, 2008).  The MG 6/85 strain vaccine is 
available for commercial use in the United States.  
Mycoplasma synoviae   
Similar to M. hyosynoviae in pigs, M. synoviae primarily causes synovitis and 
retarded growth leading to economic losses in chickens and turkeys (Walker, 2004; 
Dufour-Gesbert et al., 2006).  Respiratory signs in the form of air sacculitis are usually 
subclinical (Walker, 2004; Dufour-Gesbert et al., 2006).  Infiltration of the joints and 
tendon sheaths by heterophils, deposition of fibrin and subsynovial infiltration by 
lymphocytes and macrophages causes swollen joints and tendon sheaths (Walker, 2004; 
Bradbury, 2005).  Mycoplasma synoviae evades host immune response using variable 
surface proteins (VSP) encoded by the gene vlhA but by a different mechanism than that 
used by M. gallisepticum (Bradbury, 2005).  The methods of control and management 
used for M. gallisepticum are also used for M. synoviae (Kleven, 2008).   
Mycoplasma bovis   
Mycoplasma bovis was first described as a cause of mastitis in 1962 (Pfützner and 
Sachse, 1996).  Initially identified as M. agalactiae ssp. bovis, in 1976 it was elevated to 
a species and is now recognized as a major cause of bovine mastitis, pneumonia, and 
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arthritis in Europe, and North and South America (Pfützner and Sachse, 1996; Nicholas 
and Ayling, 2003).  While M. bovis can cause fatal pneumonia especially in calves, the 
impact of infection is primarily through the loss in production that occurs with subclinical 
and clinical mastitis (Ghadersohi et al., 1999; Nicholas and Ayling, 2003; Wilson et al., 
1997).  In the United States, between 1% and 8% of herds have at least 1 cow infected 
with Mycoplasma spp. and the most frequently identified organism is M. bovis (González 
and Wilson, 2003; Fox et al., 2005).  Clinically, mycoplasma mastitis is characterized by 
a rapid decrease in milk production, milk that is tan to grey with fibrin flakes or a gritty 
quality, an elevated SCC, and mastitis that shifts from quarter to quarter and is poorly 
responsive to antibiotics (Jasper et al., 1966; Pfützner and Sachse, 1996; González and 
Wilson, 2003).  Generally, the affected cows show only mild signs of systemic disease 
(Jasper, 1977; Pfützner and Sachse, 1996; González and Wilson, 2003).  Another disease 
syndrome caused by M. bovis consists of pneumonia, arthritis and sometimes otitis media 
primarily in calves and occasionally in mature cattle (Pfützner and Sachse, 1996; 
Nicholas and Ayling, 2003).  Morbidity due to pneumonia ranges from 20% to 100% and 
the severity of disease increases when other respiratory pathogens such as M. hemolytica, 
and P. multocida are present (Van Donkersgoed et al., 1993; Pfützner and Sachse, 1996; 
Gagea et al., 2006).  
Mycoplasma bovis is transmitted by latent carriers as well as clinically affected 
animals to susceptible individuals by direct contact (Pfützner and Sachse, 1996; Nicholas 
and Ayling, 2003; González and Wilson, 2003; Fox et al., 2005).  Contaminated milking 
equipment, personnel, and intramammary infusions used for mastitis treatment have also 
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been implicated (Pfützner and Sachse, 1996; González and Wilson, 2003; Nicholas and 
Ayling, 2003; Fox et al., 2005).  Laboratory studies have indicated environmental 
persistence under certain conditions but this has not been considered a significant factor 
in the transmission of disease (González and Wilson, 2003; Nicholas and Ayling, 2003).   
Infection by M. bovis results in pathologic lesions characterized by necrosis and 
lymphoreticular hyperplasia.  Acute mastitis is characterized by an early influx of 
eosinophils followed by degeneration of the alveolar epithelium (Van der Molen and 
Grootenhuis, 1979; Jasper et al., 1987).  As the infection progresses the interstitial tissue 
is infiltrated by lymphocytes, macrophages, plasma cells and fibroblasts, and hypertrophy 
of the epithelium (Van der Molen and Grootenhuis, 1979; Jasper et al., 1987).   This is in 
contrast to most types of bovine mastitis, where neutrophils are the predominant 
responding cell type (Paape et al., 2000).   In severe cases, the mammary gland undergoes 
atrophy and fibrosis (Jasper et al., 1987).  Mycoplasma bovis-pneumonia is characterized 
by similar pathologic changes of peribronchiolar infiltration by mononuclear cells, 
exudative bronchiolitis, lymphoreticular hyperplasia, fibrinonecrotic pneumonia and 
fibrinous pleuritis (Howard et al., 1987; Booker et al., 2008).  Infection of the joints 
causes fibrinous synovitis and synovial infusion (Blood et al., 1983; Adegboye et al., 
1995; Wilson et al., 2007).  The molecular methods of adhesion of M. bovis to host 
epithelial tissues are not well understood (Pfützner and Sachse, 1996; Thomas et al., 
2003).  Mycoplasma bovis interaction with neutrophils causes an inhibition of 
chemiluminescence (Thomas et al., 2003); as noted above, neutrophils are not a major 
type of immune cell responding to mycoplasma mastitis.  Whether the downregulation of 
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chemiluminescence is related to the poor neutrophil response against M. bovis mastitis is 
unknown.  Studies of the interactions between M. bovis and cells that typically respond to 
it, such as eosinophils, lymphocytes, or macrophages would be of interest.  Passage of M. 
bovis on artificial media results in a decrease in adhesion and a change in the expression 
of some of the vsp genes, resulting in a change in VSP expression (Thomas et al., 2003).  
Diagnosis of disease due to M. bovis can be done at the herd or individual animal 
level and is accomplished through several methods.  When the occurrence of 
mycoplasma mastitis is suspected in a dairy herd, the recommended diagnostic protocol 
is to sample the bulk tank milk 5 times every 3 to 4 d (González and Wilson, 2003; Fox et 
al., 2005; Wilson et al., 2009).  The sensitivity of a single bulk tank milk culture for 
mycoplasmas, the ability to detect Mycoplasma spp. in the bulk tank when there is at 
least 1 infected cow in the herd, has been reported as 50%.  With sensitivity of a single 
sample of 50%, the probability of not detecting infected cows with 5 samples collected 3 
to 4 d apart = (1/2)
5
 = 1/32 = 3%, resulting in a sensitivity (ability to detect at least 1 
positive milk sample in a mycoplasma-positive herd) of 97% (Wilson et al., 2009).  
Mycoplasma bovis can be reliably cultured from milk on modified Hayflick’s medium 
with an atmosphere of 8 to 10% CO2 for 7 to 10 d (Pfützner and Sachse, 1996; González 
and Wilson, 2003; Fox et al., 2005).   Mycoplasma bovis can also be cultured from 
samples of tissues and swabs from joints as long as care is taken to prevent drying and 
overgrowth by other bacteria and a transport medium favorable to mycoplasmas such as 
CVM is used (Pfützner and Sachse, 1996).  Additional methods of detecting the organism 
are with ELISA and PCR (Pfützner and Sachse, 1996; González and Wilson, 2003; Fox 
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et al., 2005).  Polymerase chain reaction is emerging as the diagnostic method of choice 
due to the shortened time needed for results and the sensitivity of the method (Pfützner 
and Sachse, 1996; Fox et al., 2005).  While an antibody response occurs with infection, 
serology is not effective at detecting chronic shedders and acutely infected individuals 
(Pfützner and Sachse, 1996; Fox et al., 2005). 
Treatment of mycoplasma mastitis is unrewarding even with antibiotics that are 
generally effective against mycoplasmas (Pfützner and Sachse, 1996; González and 
Wilson, 2003; Fox et al., 2005).  Control of mycoplasma mastitis is best done through the 
detection and removal from the herd of infected animals (Pfützner and Sachse, 1996; 
González and Wilson, 2003; Fox et al., 2005).  An infected animal may stop shedding 
bacteria in the milk but stressors such as calving may cause the disease to undergo 
recrudescence and many authors suggest that adult cows should be considered infected 
for life (Pfützner and Sachse, 1996; González and Wilson, 2003; Fox et al., 2005).  
Vaccination of cows has not been shown to be effective at eliminating disease (Pfützner 
and Sachse, 1996; González and Wilson, 2003; Fox et al., 2005). 
In addition to causing mastitis in lactating cows, M. bovis is considered to be 1 of 
the most important causes of pneumonia in both dairy and feedlot calves (Radaelli et al., 
2008; Maunsell and Donovan, 2009).  Mycoplasma bovis can be cultured from 
approximately 10% to 30% of healthy calves and 80% to 92% of herds will have at least 
1 calf which will culture positive with a nasal swab (Virtala et al., 1996; Wilson et al., 
2007; Maunsell and Donovan, 2009).  Seroconversion, which indicates infection, 
coincides with an increase in respiratory disease rates, a decrease in the rate of gain, and 
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an increase in the number of antibiotic treatments (Radaelli et al., 2008; Maunsell and 
Donovan, 2009).  In studies of calves dying from pneumonia, M. bovis has been isolated 
alone or with other respiratory pathogens in 30% to 50% of the cases (Virtala et al., 1996; 
Maunsell and Donovan, 2009).   
There appears to be a difference in the epidemiology of M. bovis pneumonia in 
dairy calves and beef calves; a higher proportion of dairy calves contract mycoplasma 
infections at an earlier age than do beef calves (Gagea et al., 2006; Booker et al., 2008; 
Maunsell and Donovan, 2009).  Mycoplasma bovis can be cultured from dairy calves as 
young as 1 wk of age and clinical disease is generally diagnosed in calves 2 to 6 wk old 
(Maunsell and Donovan, 2009).  In herds with mycoplasma mastitis, up to 50% of calves 
will have positive nasal cultures (Maunsell and Donovan, 2009).  In contrast, in beef 
calves, only approximately 20% have a positive antibody titer against M. bovis upon 
arrival at a feedlot (after weaning at approximately 6 mo of age).  The difference in ages 
at which mycoplasma pneumonia is seen in dairy as compared to beef calves is probably 
due to the calf management practices typically used in the 2 industries.  The practice of 
feeding pooled colostrum and discard milk to dairy calves has been shown to transmit M. 
bovis to calves, with most developing positive nasal cultures within 2 wk and 37% 
developing otitis media (Maunsell and Donovan, 2009).  In the beef industry, calves 
generally stay with the cow until weaning. 
Similar to M. bovis mastitis, treatment of mycoplasma calf pneumonia is 
generally unrewarding; calves can improve with early treatment with antibiotics such as 
tulathromycin, florfenicol, tilmicosin, and tylosin, but long term prognosis is guarded and 
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weight gain is reduced (Rosendal and Martin, 1986; Nicholas and Ayling, 2003; 
Maunsell and Donovan, 2009).  Management and control methods include pasteurization 
of milk and colostrum, segregation of new arrivals to feedlots, metaphylactic (timely 
mass medication of a group of animals to eliminate or minimize an expected outbreak of 
disease) administration of antibiotics, and possibly improving ventilation and minimizing 
crowding (Maunsell and Donovan, 2009).  Vaccine trials have shown mixed results.  In 
some trials, vaccinated groups have had a reduction of clinical disease, an increase in 
weight gain and a reduced mortality compared to control groups but in other tests, 
vaccination has appeared to exacerbate disease (Maunsell and Donovan, 2009).  Because 
calves are infected at a very early age, developing an effective vaccine is a challenge 
(Maunsell and Donovan, 2009). 
Mycoplasma dispar   
Mycoplasma dispar is isolated more frequently from healthy calves (prevalence as 
high as 90%) than M. bovis, and its role as a primary pathogen is somewhat questionable 
(Howard, 1983; Marques et al., 2007; Maunsell and Donovan, 2009).  The organism was 
identified and characterized in 1968 using a modification of Goodwin’s media (Gourlay 
and Leach, 1970).  In that study of both normal and pneumonic calves, the organism was 
not isolated from normal calves but was found in 49 of 72 of the diseased calves (Gourlay 
and Leach, 1970).  In contrast, a study of 155 calves with respiratory disease and 146 
apparently healthy calves found M. dispar in 35% and 9% of the calves, respectively; M. 
bovis was found only in diseased animals (prevalence 12%; Marques et al., 2007).  
Additional studies have found that many of the apparently healthy calves with positive M. 
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dispar cultures actually have subclinical pneumonia upon histopathologic examination of 
the lungs (Howard, 1983).   Ultimately, it appears that M. dispar contributes to pathologic 
processes which lead to respiratory disease in calves but because the pathologic 
mechanism is more subtle and because the organism is fastidious in its growth 
requirements, that contribution has been underestimated (Howard et al., 1987; Ayling et 
al., 2004). 
Mycoplasma dispar does not grow on conventional mycoplasma media but grows 
well on a medium with glucose, calf serum, lactalbumin lysate, Hartley’s digest broth, 
and homogenized calf thymus (Gourlay and Leach, 1970). On solid media, the colonies 
appear lacy with a poorly defined center (Gourlay and Leach, 1970).  With repeated 
passage, the colonies become more numerous and smaller exhibiting characteristics of 
other mycoplasmas (Gourlay and Leach, 1970).  Mycoplasma dispar also grows well on 
Friis’ medium (Table 1.2) and its use has increased the number of isolations in Britain 
(Ayling et al., 2004). 
In 1 study of calves with pneumonia, the lesions associated with M. dispar were 
fibrinonecrotic bronchopneumonia and suppurative bronchopneumonia (Tegtmeier et al., 
1999).  In 84% of the cases, more than 1 organism was isolated (Tegtmeier et al., 1999).  
In gnotobiotic calves, the lesions have been described as subtle and primarily consisting 
of an alveolitis (Howard et al., 1987).  Macrophages appear to be the predominant cell 
type found at calf lung infection sites with M. dispar (Howard et al., 1987).  The disease 
course in the gnotobiotic calves was usually subclinical (Howard et al., 1987).  
Mycoplasma dispar appears to affect the course of infection by other bacteria, most often 
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P. multocida, by causing ciliostasis (Howard et al., 1987; Virtala et al., 1996; Maunsell 
and Donovan, 2009).  A study of the effect of M. dispar on an organ culture of bovine 
trachea found a marked degeneration of the epithelium, loss of movement in the cilia, and 
markedly reduced clearance of Serratia marcescens (Almeida and Rosenbusch, 1994).  
Attempts to immunize calves against M. dispar have not been successful because the 
organism is poorly immunogenic and may even suppress the immune system (Howard et 
al., 1987).  Management strategies consist of minimizing stress by addressing ventilation, 
temperature, and crowding issues and maximizing fitness with adequate nutrition, and 
vaccination for other respiratory diseases (Maunsell and Donovan, 2009).  
Mycoplasma agalactiae   
Mycoplasma agalactiae causes a disease syndrome in goats and sheep that is very 
similar to that of M. bovis in cattle.  While the common name of the syndrome is 
contagious agalactia and mastitis predominates, keratoconjunctivitis, arthritis (especially 
in young animals), and occasionally pleurisy also occur (DaMassa et al., 1992; Smith and 
Sherman, 1994).  Mycoplasma agalactiae has also been associated with granular 
vulvovaginitis of goats (DaMassa et al., 1992).  Upon infection, there is a decline in milk 
production and the udder may become hot, swollen, and tender (Kahn and Line, 2005).  
The milk can have a granular consistency and be yellow in color (Smith and Sherman, 
1994; Kahn and Line, 2005). The gland can atrophy and the loss of milk production can 
be permanent (Kahn and Line, 2005).  Chronically infected sheep or goats shed 
organisms in milk and become carriers of the disease (Smith and Sherman, 1994; 
McAuliffe et al., 2008).  In susceptible herds morbidity can be 30% to 60% (Kahn and 
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Line, 2005).  Also like M. bovis, M. agalactiae can be transferred by milking equipment, 
workers, and by feeding infected milk (DaMassa et al., 1992; Smith and Sherman, 1994; 
Kahn and Line, 2005).  Microbial culture and PCR can be used to detect the organism in 
tissues and milk (Kahn and Line, 2005).  Serological tests such as CF, Western blot, and 
ELISA can be used to identify infected herds but not for the individual animal because 
the serologic response is variable and there is cross reaction with other mycoplasma 
species (see discussion for CCPP, Smith and Sherman, 1994).  Recently developed serum 
ELISA tests have improved sensitivity (100%) and specificity (46% to 92% depending on 
the test), respectively (Pépin et al., 2003).  The test with the highest specificity uses a 
recombinant antigen, P48, a mycoplasma surface membrane protein (Pépin et al., 2003).  
Management is more effective than antibiotic treatment for control of the disease (Kahn 
and Line, 2005).  A recently developed inactivated mineral-oil adjuvanted M. agalactiae 
vaccine administered in 2 doses has been shown to prevent clinical disease in sheep 
challenged intranasally for up to 8 months following the second vaccination 
(Buonavoglia et al., 2010). 
Mycoplasma spp. in Wildlife   
A number of mycoplasmas have been identified in wildlife, and both newly 
described organisms and new hosts for already characterized organisms are being 
identified on a regular basis (Kirchoff et al., 1997; Helmick et al., 2002; Hammond et al., 
2003; Haulena et al., 2006).  The disease syndromes of conjunctivitis, 
bronchopneumonia, polyarthritis, and reduced fertility associated with mycoplasma 
infection in wildlife are similar to those that have been described for domestic animals 
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(Kirchoff et al., 1997; Helmick et al., 2002; Hammond et al., 2003; Haulena et al., 2006).  
There are several differences between the investigation of diseases in wildlife and 
domestic animals.  The identification of outbreaks is generally more difficult because the 
populations of interest are more dispersed and less accessible.  When death occurs, the 
remains are often discovered in a state of moderate to severe degeneration.  The result is 
that isolation of the responsible agent and satisfying the requirements of Koch’s 
postulates is difficult.  The epidemiology, pathology, and population effects of M. 
gallisepticum, M. ovipneumoniae, and M. agassizii on populations of the house finch, 
bighorn sheep, and tortoises, respectively, are examples of the difficulties of wildlife 
disease investigation as well as the effects of mycoplasmas on wildlife populations 
(Wobeser, 1994; Rudolph et al., 2007). 
Respiratory disease in free-ranging desert tortoises (Gopherus agassizii) was first 
observed in the 1970’s in the Beaver Dam Slope region of southern Utah (Brown et al., 
1994).  At the same time, population declines had been observed in both the desert 
tortoise and the gopher tortoise (G. polyphemus).  Tortoises are considered by many 
ecologists to be a keystone species in the biome because their dens provide support for 
many other species (Brown et al., 1999b).  Because of their importance, captive breeding 
programs and research stations were established for both species.  In 1988, an outbreak of 
respiratory disease occurred on an isolated research station in southern California (Brown 
et al., 1999a).  There was an 86% decline in the population and a 94% decline in adult 
animals (Brown et al., 1999a).  Investigations of free-ranging desert tortoises found a 
mycoplasma, later named M. agassizii, on the surface of the nasal mucosa of affected 
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tortoises (Brown et al., 1994).  Experimental infection of captive tortoises with M. 
agassizii resulted in 7 of 8 animals developing clinical disease; the organism was 
recovered from 5 of 7 and a rising titer developed in all exposed animals (Brown et al., 
1994).  Studies of free-ranging tortoises have also documented rising titers in association 
with clinical signs and increasing prevalence levels of M. agassizii (Brown et al., 1999a; 
Dickinson et al., 2005).  In addition to desert tortoises, M. agassizii has also been isolated 
from gopher tortoises and Geochelone spp. (Brown et al., 1999b).   
  Infection of tortoises with M. agassizii is characterized by a nasal discharge that 
varies from serous to mucoid to purulent, increased lacrimation, conjunctivitis, edema of 
the eyelids, anorexia, dehydration, and death (Brown et al., 1999b; Dickinson et al., 
2005).  Histologically the infection causes hyperplasia of the epithelium of the affected 
tissues, loss of cilia in the respiratory epithelium, and accumulation of lymphoid 
aggregates (Brown et al., 1994; Brown et al., 1999b).  Detection of the organism is most 
efficient with serology via ELISA or PCR (Brown et al., 1999a; Dickinson et al., 2005).  
Culture is more difficult than usual for a mycoplasma with growth occurring in 4 to 6 
weeks on SP4 media (Brown et al., 1999b).  Continued epidemiological studies have 
determined that the typical course of the disease is chronic with some animals remaining 
infected for more than a year (Brown et al., 1994; Brown et al., 1999b).  It is highly 
probable that stressors such as drought, changes in vegetation, and human activities 
impact the occurrence of disease (Brown et al., 1999a; Dickinson et al., 2005). 
The impact and occurrence of M. ovipneumoniae in wild sheep is similar to that 
of M. agassizii in tortoises.  The first documented disease outbreak occurred in a herd of 
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captive Dall’s sheep (Ovis dalli), a species that is closely related to bighorn sheep (O. 
canadensis) that were maintained by the Toronto zoo (Black et al., 1988).  The outbreak 
started when 2 ewes were returned to the herd after a stay at an outside facility where 
they had been housed next to a pair of domestic sheep (Black et al., 1988).  Two months 
after they were returned to the herd, 7 of 10 individuals were coughing (Black et al., 
1988).  Ten days after the appearance of disease, 40% of the animals had severe 
respiratory distress and despite treatment with several antibiotics and flunixin 
meglumine, 2 individuals died (Black et al., 1988).  One year after the outbreak some of 
the animals still had poor body condition and exercise intolerance (Black et al., 1988).  
Since then, M. ovipneumoniae has been associated with several disease outbreaks in 
species of bighorn sheep throughout the western United States (Rudolph et al., 2007; 
Besser et al., 2008).   
The pathology caused by the M. ovipneumoniae was well described in the 
outbreak at the Toronto zoo and has been consistent in subsequent disease occurrences.  
Fibrinopurulent bronchopneumonia and fibrinous pleuritis are common with the most 
severe lesions occurring in the right cranial lobe (Black et al., 1988; Rudolph et al., 2007; 
Besser et al., 2008).  Microscopically, early lesions have a hyperplastic bronchiolar 
epithelium (Black et al., 1988; Rudolph et al., 2007; Besser et al., 2008).  As the disease 
progresses, lymphoid cuffing, congestion, fibrosis, and necrosis occurs (Black et al., 
1988; Rudolph et al., 2007; Besser et al., 2008).  Otitis media has also been documented 
in bighorn sheep lambs (Besser et al., 2008). 
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Identification of M. ovipneumoniae in the tissues of affected animals has been 
difficult and initially the outbreaks of pneumonia in wild sheep were attributed to 
Pasteurella spp. and Mannheimia hemolytica (Rudolph et al., 2007; Besser et al., 2008).  
Use of Friis’ media appears to improve isolation (Black et al., 1988; Rudolph et al., 2007; 
Besser et al., 2008).  As with other mycoplasmas which are difficult to culture, both PCR 
and serologic tests have been described as efficient at detecting the occurrence of M. 
ovipneumoniae in populations.  However, sensitivity and specificity calculations have not 
been reported (Black et al., 1988; Besser et al., 2008). 
The appearance of M. gallisepticum in house finches (Carpodarcus mexicanus) 
and other passerines in 1994 was both similar and unique in comparison to outbreaks of 
mycoplasmal disease in other wildlife species.  The characteristics of this disease 
syndrome are dependent upon host and agent factors (Dhondt et al., 2005).  The house 
finch populations of the eastern United States originated from a group of less than 300 
birds imported from the western United States in the 1940s and as such have limited 
genetic diversity (Fischer et al., 1997; Dhondt et al., 2005).  Genetic analysis of M. 
gallisepticum isolates from affected birds in 11 states found the isolates to be identical 
indicating a single emergence event in late 1993 or early 1994 which has been localized 
to the Washington D.C. area (Fischer et al., 1997; Dhondt et al., 2005).  This strain 
differed from laboratory reference, vaccine, and poultry strains; however newer DNA 
sequencing methods have placed the strain in a cluster with strains isolated from poultry 
(Dhondt et al., 2005).  The infection causes conjunctivitis that varies from mild to severe 
and from which some birds can recover (Luttrell et al., 1998; Dhondt et al., 2005).  In 
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spite of this, Christmas bird counts and feeder counts carried out by thousands of bird 
watchers across the US documented population decreases of up to 60% in the susceptible 
species (Dhondt et al., 2005).   
Infection of susceptible individuals by M. gallisepticum is characterized by mild 
to severe ocular swelling, conjunctivitis, nasal and ocular discharge, and decreased body 
condition (Fischer et al., 1997; Luttrell et al., 1998).  In a natural outbreak in a group of 
captive birds, coughing, sneezing, and rales were not observed (Luttrell et al., 1998).  
Histologically, lesions are limited to the periocular tissues, nasal turbinates, and the 
trachea (Fischer et al., 1997; Luttrell et al., 1998).  Consistent with other mycoplasma 
disease, lesions are characterized by mild to severe lymphoplasmacytic infiltrates, 
epithelial hyperplasia, and in some cases heterophilic infiltrates (Luttrell et al., 1998). 
Experimentally, all finch (Fringillidae) species tested appear to be susceptible 
(Farmer et al., 2005).  Additional susceptible species include the pine siskin (Carduelis 
pinus), tufted titmouse (Baeolophus bicolor), the house sparrow (Passer domesticus), and 
the budgerigar (Melopsittacus undulates, Farmer et al., 2005).  A survey of songbirds in 
Auburn, Georgia detected antibodies to M. gallisepticum in 20 species (Farmer et al., 
2005).  Polymerase chain reaction detected M. gallisepticum in 6 species: American 
goldfinch (Carduelis tristis), tufted titmouse (Baeolophus bicolor), pine grosbeak 
(Pinicola enucleator), evening grosbeak (Coccothraustes vespertinus), house finches 
(Carpodarcus mexicanus), and the purple finch (Carpodacus purpureus; Farmer et al., 
2005).  Factors affecting the epidemiology of the disease are the adaptation of these 
species to human land use patterns, seasonal migration of the eastern populations of 
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finches, the use of birdfeeders which increases contact between birds and allows sick 
birds to live longer, and the partial immunity that results from infection (Fischer et al., 
1997; Dhondt et al., 2005).  The persistence of the disease in the eastern United States is 
characterized by regional and seasonal epidemics (Hartup et al., 2000; Dhondt, et al., 
2005; Farmer et al., 2005).  Occasionally outbreaks occur in the western bird populations 
(Dhondt et al., 2005).  
Summary of Mycoplasma Disease   
This review of diseases caused by mycoplasmas in man and animals has 
demonstrated many similarities.  While the course of mycoplasma infections can be acute 
as with CBPP and CCPP, a chronic course is more typical.  Coinfection with other 
bacteria, such as E. coli or Pasteurella spp., or with viruses, such as influenza or 
circovirus, can increase the severity of the pathology observed.  The pathological lesions 
often involve lymphoreticular hyperplasia and fibrinous or fibrinonecrotic degeneration 
of lungs, mammary glands, joints and other affected tissues.  Identification by culture of 
the causative mycoplasma is made more difficult by complex and prolonged growth 
requirements.  Serologic methods of diagnosis are often used but both the sensitivity 
and/or specificity of many tests frequently limits the usefulness for individual animal 
diagnosis.  Molecular methods, such as various types of PCR, show promise as both 
practical and accurate diagnostic methods and many diagnostic laboratories are in the 
process of validating various protocols.  In addition, PCR is being used to detect 
previously unrecognized mycoplasmas in domestic animals and wildlife. 
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Mycoplasmas and the Immune System 
Response   
Mycoplasmas have been found to interact with many different host cell types:  
macrophages, polymorphonuclear (PMN) cells, monocytes, follicular dendritic cells, 
synovial cells, respiratory epithelial cells, and astrocytes.  These interactions result in a 
number of immune system reactions.  The mycoplasma organisms are able to resist 
phagocytosis unless opsonized by specific antibodies (Razin et al., 1998).  Both host and 
organism strain differences influence the immune reaction and the persistence of the 
organisms.  Even when evading phagocytosis, mycoplasmas can increase the destruction 
of other cells and bacteria by non-specifically stimulating the immune system to produce 
enzymes, prostaglandins, toxic oxygen moieties and peroxides, nitric oxide, 
proinflammatory cytokines, and chemokines (Razin et al., 1998). 
An early in vitro study found that bovine anti-serum specific for M. bovis and M. 
dispar increased the ability of cultured bovine alveolar macrophages (BAM) and PMN to 
reduce the number of mycoplasmas in the culture supernatant but when rabbit anti-serum 
to the same organisms was used, growth of the mycoplasmas occurred (Howard et al., 
1976).  This indicates that opsonization of the organisms with antibodies allows immune 
cells to kill the organisms only when the antibodies are from the same species as the 
cells.  Researchers soon determined that some mycoplasmas attached to and even 
replicated on the surface of phagocytic cells indicating that the process observed in vitro 
was not the same as the process in the animal (Howard et al., 1987; Almeida et al., 1992).  
The attachment of mycoplasmas to immune cells could allow the organisms to persist and 
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was hypothesized to contribute to the pathology of the disease syndromes (Howard et al., 
1987).  A reduction in the severity of lesions could be observed when the immune 
response was inhibited pharmacologically suggesting that at least part of the part of the 
disease syndrome was due to the host immune response (Howard et al., 1987).  As 
immunohistochemistry for various cell types developed, researchers found that the lungs 
of calves infected with M. bovis contained few PMN cells, and large numbers of mature 
macrophages (Howard et al., 1987).  At 2 weeks post-infection immunostaining 
determined that IgG1-containing plasma cells predominated with smaller numbers of 
cells containing IgM, IgG2, and IgA.  However, by 4 weeks post-infection, more plasma 
cells containing IgG2 were present (Howard et al., 1987).  A comparison was made with 
calves infected with M. dispar; relatively more IgA producing cells were detected 
especially in the cells of the submucosa of the trachea relative to calves infected only 
with M. bovis (Howard et al., 1987). 
Immunosuppression has been documented in patients infected with certain species 
of mycoplasmas (Howard et al., 1987; Almeida et al., 1992; Razin et al., 1998).  
Mycoplasma pneumoniae causes a decrease in the response to intradermal tuberculin 
(Howard et al., 1987; Razin et al., 1998).  Mycoplasma dispar reduced the serologic 
response of calves to M. bovis when the calves were simultaneously injected with both 
organisms (Howard et al., 1987).  Mycoplasma dispar also reduced the lymphocyte 
transformation response to bovine respiratory syncytial virus when both were injected 
into calves (Howard et al., 1987).  The lymphocytes of cattle infected with M. mycoides 
ssp. mycoides have a reduced ability to respond to mitogens (Howard et al., 1987).   
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The inhibitory effect of mycoplasmas on the immune systems of their respective 
hosts is accomplished through different mechanisms, a few of which have been 
investigated with advanced biochemical and genomic techniques.  The responses of BAM 
in cell culture to encapsulated and unencapsulated M. dispar were characterized by 
measuring the production of tumor necrosis factor (TNF), interleukin 1 (IL-1), and 
glucose (Almeida et al., 1992).  For all 3 products, exposure to the purified capsule or the 
whole encapsulated organism reduced production by BAM (Almeida et al., 1992).  
Moreover, the BAM were unresponsive to endotoxin in the presence of purified capsule 
(Almeida et al., 1992).  Mycoplasma dispar produces a capsule in vivo as well as in 
culture (Almeida et al., 1992).  Mycoplasma hyorhinis releases a protein which 
suppresses an interleukin-2 (IL-2) dependent cytotoxic T lymphocyte response and T cell 
memory (Razin et al., 1998).  A deficit of IL-2 also occurs with the suppression of the in 
vitro lymphocyte proliferation by M. mycoides ssp. mycoides LC (Poonia and Sharma, 
1998).  Mycoplasmas may be able to adhere to and cause death by apoptosis of host 
animal T cells.  Calves infected with M. bovis showed suppressed lymphocyte activity 
even though the lymphocytes were not killed as determined by trypan blue exclusion 
(Thomas et al., 1990; Razin et al., 1998).  Subsequent research using propidium iodide 
incorporation, translocation of phosphatidyl serine, detection of a decrease in cell size by 
flow cytometry, and detection of DNA ladder generation (an indicator of DNA 
fragmentation) determined that there was a loss of cells occurring by apoptosis (Vanden 
Bush and Rosenbusch, 2002).  A product of the vsp gene family, VSP-L, was found to 
suppress lymphocyte proliferation (Vanden Bush and Rosenbusch, 2004).  An analogous 
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protein, a product of the avgC gene was identified for M. agalactiae (Santona et al., 
2002).  
Many mycoplasma species affect the immune system by causing effector cells to 
produce cytokines, both stimulatory and inhibitory, and chemoattractants (Razin et al., 
1998; Yang et al., 2002; Vanden Bush and Rosenbusch, 2003; Thanawongnuwech et al., 
2004; Sun et al., 2006).  Mycoplasma bovis, M. capricolum, M. gallisepticum, M. 
synoviae, M. hyopneumoniae, M. hyorhinis, and M. mycoides ssp. mycoides induce 
macrophages to produce TNF-α, a cofactor for B and T lymphocyte proliferation and 
differentiation.  Many of the mycoplasmas also increase the production of additional 
stimulatory cytokines such as IL-1, IL-1β, IL-6, and IFN-α (Razin et al., 1998).  In 
contrast, production of proinflammatory TNF-α by macrophages is inhibited by M. dispar 
(Razin et al., 1998).  Mycoplasma bovis stimulation of TNF-α and interleukin-β occurred 
at 100 hours post infection and continued until the end of the study (240 hours) of 
experimentally infected cows (via mammary gland infusion; Kauf et al., 2007).  
Compared to other organisms that cause intra-mammary infections such as Streptococcus 
uberis and Escherichia coli, the induction is delayed by as much as 60 h; this may help 
M. bovis to become established in the mammary gland, contributing to its greater 
likelihood of becoming a cause of chronic mastitis than S. uberis or E. coli (Kauf et al., 
2007; González and Wilson, 2003).  Subtle strain variations have been detected in the 
pattern of macrophage cytokine production (Jungi et al., 1996). 
Mycoplasma pneumoniae, M. arthritidis, M. fermentens, M. hyopneumoniae, M. 
pulmonis, and M. bovis infections are also associated with production of the inhibitory 
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cytokine, IL-10, usually later in the course of infection (Razin et al., 1998; 
Thanawongnuwech et al., 2004; Sun et al., 2006; Kauff et al., 2007).  Mice strains 
susceptible to M. pneumoniae expressed more IL-10 mRNA than resistant mice when 
exposed to antigen (Sun et al., 2006).  Furthermore, the expression of IL-10 mRNA 
increased with increasing disease severity (Sun et al., 2006).  While pulmonary alveolar 
macrophages harvested with bronchoalveolar lavage (BAL) demonstrated increased 
production of IL-10 mRNA in pigs infected with M. hyopneumoniae, increased amounts 
of IL-10 were not detected in the BAL fluid (Thanawongnuwech et al., 2004).  The 
authors did not discuss this incongruity but it could be due to sequestration of IL-10 
within the lung tissues.  Cytokine IL-10 levels were increased in the supernatant of co-
cultured pulmonary alveolar macrophages and tracheal rings but the IL-10 was not 
detected in the macrophages which suggests that epithelial cells possess the ability to 
produce this cytokine (Thanawongnuwech et al., 2004).  Mycoplasma bovis increases IL-
10 production in experimentally infected mammary glands 90 hours post-infection; 
simultaneous milk sampling determined that there were greater than 10
6
 cfu/ml of M. 
bovis in milk at that time (Kauf et al., 2007).  The increased production of IL-10 could be 
an attempt by the immune system to limit the damage or due to direct stimulation by an 
as yet unidentified effector molecule from the mycoplasma (Razin et al., 1998; Sun et al., 
2006).  The end result, however, could be impaired clearance of pathogenic organisms 
due to the suppression of macrophage function (Thanawongnuwech et al., 2004; Sun et 
al., 2006).  
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Mycoplasmas are capable of stimulating B cells, T cells, natural killer cells, and 
macrophages.  Some B cells may become antibody-producing plasma cells, but the 
antibodies are not necessarily specific for mycoplasma antigens (Razin et al., 1998).  The 
non-specific antibodies in combination with the upregulating cytokines further amplify 
the inflammatory process and as a result downregulating cytokines are then produced by 
effector cells while pathogenic organisms are still present (Razin et al., 1998; Vanden 
Bush and Rosenbusch, 2003).  This process both reflects and likely contributes to the 
chronic nature of many mycoplasma infections (Razin et al., 1998; Vanden Bush and 
Rosenbusch, 2003).   
Autoimmunity  
An additional characteristic of mycoplasma infections is the induction of an 
autoimmune process.  One mechanism for this effect is the occurrence of shared epitopes 
(the part of the macromolecule that is recognized by the immune system) between the 
mycoplasma and the host (Razin et al., 1998).  Mycoplasma penetrans, which occurs as 
an AIDs-associated illness, causes immune system activation in humans through a 
complex process that includes glycolipid and lipoprotein mediators (Razin et al., 1998).    
Mycoplasma penetrans shares an epitope with CD18, an adhesin that stimulates the 
immune system by mediating the interactions between various macrophages and 
lymphocytes (Razin et al., 1998).  Similar shared epitopes have been found for M. 
mycoides ssp. mycoides, M. gallisepticum, M. hyorhinis, M. genitalium, M. pneumoniae, 
and M. arthritidis (DeVay and Adler, 1976; Davis et al., 1981; Razin et al., 1998). 
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Immune Evasion by Mycoplasmas   
In addition to influencing the character of the immune reaction by stimulating the 
production of various cytokines and enhancing the maturation of lymphocyte cell lines, 
several mycoplasmas possess an ability to rapidly change surface epitopes.  The 
mechanisms of this process have been studied for several species of mycoplasmas and 
have been found to consist of several types of genetic recombination events (Razin et al., 
1998; Beier et al., 1998; Lysnyansky et al., 2001; Nussbaum et al., 2002; Flitman-Tene et 
al., 2003).  As different strains of M. bovis were subjected to antigenic analysis, 
researchers became aware that there was incomplete understanding of the mechanisms by 
which strain variation was generated (Rosengarten et al., 1994).   
In an early study using MAb, researchers determined that a single epitope 
occurred in several different sized integral membrane proteins in several strains of M. 
bovis.  It was determined by use of an immunoblot method that this variation occurred in 
colonies of M. bovis on a culture plate, thus indicating the rate of change was higher than 
could be accounted for by random mutation.  By examining several different strains 
isolated from clinical cases of mastitis, pneumonia, and arthritis and 2 healthy calves it 
was determined that the variability of epitope expression could not be correlated with 
pathogenicity or the site of isolation.  When a chronically infected calf was serially 
sampled, similar changes in the membrane proteins were detected indicating that the 
same process occurs in vivo (Rosengarten et al., 1994). 
Research has progressed with the development of gene and protein sequencing 
methods.  The genes that code for the VSP have been identified for M. bovis (vsp), M. 
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hyorhinis (vlp), M. pulmonis (vsa), and M. agalactiae (avg; Razin et al., 1998; Beier et 
al., 1998; Lysnyansky et al., 2001; Nussbaum et al., 2002; Flitman-Tene et al., 2003).  
The mechanisms used by each species to attain the maximum amount of variation from a 
limited genome are similar and in the case of M. agalactiae and M. bovis, homologous 
gene segments are present (Flitman-Tene et al., 2003).  Many other bacteria have similar 
methods of generating phenotype variability from a single genotype but mycoplasmas are 
unique in the amount of variability generated (Razin et al., 1998). 
 The common characteristics of these gene families are an N-terminal region that 
contains a prokaryotic lipoprotein signaling sequence, an exposed C-terminal region of 
repetitive units, and an initiation codon that is subjected to site-specific insertion and 
deletion (Razin et al., 1998; Beier et al., 1998; Flitman-Tene et al., 2003).   The result is a 
combination of phase and size variation of the resulting gene product (Razin et al., 1998; 
Beier et al., 1998; Flitman-Tene et al., 2003).  Phase variation occurs in M. bovis, M. 
pulmonis, and M. agalactiae by means of site-specific intergenic recombination and 
inversion events (Razin et al., 1998; Lysnyansky et al., 2001; Flitman-Tene et al., 2003).  
This mechanism is facilitated by a DNA recombinase in the λ-integrase family (Flitman-
Tene et al., 2003).  Size variation of membrane proteins occurs in M. bovis, M. hyorhinis, 
M. hominis, and M. pneumoniae and occurs by the insertion or deletion of repetitive 
sequence (Razin et al., 1998; Beier et al., 1998).  In M. bovis and M. hyorhinis it is 
independent of phase variation (Razin et al., 1998).  Finally, there is a rapid ON/OFF 
switching of the multiple copies of the membrane protein genes by either insertion of an 
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initiator or promoter codon (Razin et al., 1998; Lysnyansky et al., 2001; Flitman-Tene et 
al., 2003). 
Mycoplasmas elicit a mixture of immunostimulatory, immunosuppressive, and 
autoimmune reactions, as well as use surface modification to attempt to evade detection 
by the host’s immune system in an effort to continue to reproduce while the host’s 
immune system strives to eliminate the undesirable organisms.  For many mycoplasmas, 
such as M. hyorhinis, M. bovirhinis, and M. salivarium and the host species to which they 
are adapted, the balance of elimination and reproduction is relatively even and the lesions 
that are produced, minimal (Jungi et al., 1996; Razin et al., 1998; Mahon et al., 2007).  
Variations in both host and pathogen characteristics can shift the balance and cause 
severe disease to occur.  While M. bovis can be isolated from 30% to 50% of calves 
dying from pneumonia and cultured from the nasal cavity of 20% of apparently healthy 
calves, and 90% of mixed age herds have at least 1 calf that will culture positive, only 8% 
of dairy herds will have any mycoplasma, usually M. bovis, in adult cows (González and 
Wilson, 2003; Maunsell and Donovan, 2009).  Variations in cytokine production by 
individuals may explain differences in disease susceptibility.  In 1 study of 
experimentally induced intramammary infection, 3 out of 4 cows had equal amounts of 
IFN-γ and IL-4 producing cells and 1 cow had a significantly greater percentage of IL-4 
producing cells.  Because IFN-γ is generally classified as stimulating the immune system 
and IL-4 causes a downregulation in many immune functions, this difference could 
dramatically alter the course of disease.  Similar differences have been detected between 
M. pulmonis resistant and susceptible strains of mice (Sun et al., 2006).  Variations in 
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antigenicity, cytokine induction, and immune modulation have been documented in field 
isolates and laboratory cultured mycoplasmas but it has been difficult to connect these 
variations to changes in pathogenicity and disease syndromes (Beier et al., 1998; Thomas 
et al., 2003; Maunsell and Donovan, 2009).  It is well recognized that mycoplasmas 
become less pathogenic when cultivated in the laboratory and this has been used to 
produce vaccines for M. gallisepticum (Whithear, 1996; Kleven, 2008).  Another 
imbalance between host immunity and the invading pathogenic mycoplasma occurs when 
a naïve host species becomes infected as occurs with bighorn sheep and M. 
ovipneumoniae, and with house finches and M. gallisepticum.  In both of these species, 
the introduction of disease was accompanied by notable population declines (Dhondt et 
al., 2005; Besser et al., 2008).  For many of the mycoplasmas of veterinary importance, 
the impact of the disease lies not with the severity of disease but with the rate of 
morbidity and the impact on production. 
Summary of literature review 
 In summary, mycoplasmas cause disease in a wide range of animal and bird 
species as well as in humans.  Infection with these organisms can result in death but more 
often results in chronic disease, and in the case of livestock, reduced production.  
Mycoplasmas are often difficult to identify as the agents of the disease process because of 
their characteristics of growth in culture and the need for specialized media.  In addition, 
development of antibodies by the host in response to infection is variable making 
serologic testing unreliable for detection of infection in individual animals.  Areas in need 
of additional research in regards to mycoplasma infections are defining virulence factors, 
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improving detection of organisms which have prolonged growth curves or fastidious 
growth requirements, developing methods which facilitate speciation of closely related 
organisms, and incorporating an understanding of microbial ecology into modes of 
transmission and environmental persistence. 
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CHAPTER 3 
SURVIVAL AND REPLICATION OF MYCOPLASMA SPECIES IN RECYCLED 





Infection with Mycoplasma spp., typically M. bovis, is an important disease 
complex of dairy cattle. Mycoplasma spp. can cause mastitis, arthritis, metritis, 
pneumonia, septicemia, and death of cattle (Pfützner and Sachse, 1996; Wilson et al., 
2007; Wilson et al., 2009).  Standard microbial cultures of milk samples do not isolate 
Mycoplasma spp.; special methods are necessary.  Therefore, the presenting history 
associated with mycoplasma mastitis often includes a frustrating inability to determine 
the causative agent after clinical signs appear because of repeated negative results on 
standard microbial cultures of milk samples (González et al., 1992; Wilson et al., 2007).  
Culled or dead cows, lameness, respiratory disease in calves or adult cattle, and clinical 
mastitis which does not respond well to treatment can cause considerable financial loss 
(Pfützner and Sachse, 1996).  Per case, mycoplasmal infections cause some of the largest 
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milk production losses among all mastitis pathogens (Wilson et al., 1997).  Mycoplasma 
infections are contagious diseases, and are primarily transmitted by milk from infected 
cows which contaminates milking equipment and by direct contact with respiratory 
secretions (Jasper, 1977; González et al., 1993; Ghazaei, 2006).    
During the follow up phase of a statewide prevalence study of mycoplasma 
mastitis in Utah, we discovered an outbreak of clinical mycoplasma mastitis on a 4,500 
cow dairy farm. This disease outbreak was associated with the isolation of Mycoplasma 
spp. from stored recycled bedding sand and from freestall bedding.  An earlier reported 
outbreak of mycoplasma mastitis in a Florida dairy herd was associated with a 
mycoplasma-positive sandlot that was used for calving and to house mastitic cows (Bray 
et al., 1997).  Additionally, seasonal variation of mycoplasma mastitis has been reported 
(González et al., 1992; Bray et al., 1997; González and Wilson, 2003) which could 
partially be attributed to seasonal cow stress, but environmental sources may play a role 
(Bray et al., 1997).  Thus, the existence of environmental sources for Mycoplasma spp., 
including M. bovis, and their role in transmission and clinical disease needs further 
investigation.  
The objectives of this study were to evaluate the concentration of Mycoplasma 
spp. in recycled bedding sand, investigate factors associated with the survival of the 
Mycoplasma spp. in recycled bedding sand and determine whether recycled bedding sand 
can serve as an environmental source of mycoplasmal infections of dairy cows.  The null 
hypothesis was that Mycoplasma spp. would not persist in the recycled bedding sand 
without constant exposure to infected cows.  The first alternative hypothesis was that 
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Mycoplasma spp. would persist for a period of time without exposure to infected cows 
but then numbers detected would eventually decline to zero.  The second alternative 
hypothesis was that Mycoplasma spp. numbers would fluctuate over time suggesting 
changes in response to changing conditions.  We also evaluated 2 methods of elimination 
of Mycoplasma spp. from contaminated bedding sand.  Confirmation of an environmental 
source for Mycoplasma spp. in recycled bedding sand and its association with 
mycoplasma-related clinical disease raises possibilities for further investigation of 
mycoplasma disease in dairy cattle and could impact management strategies.  
Materials and Methods 
Study Dairies   
Mycoplasma-positive dairy herds were identified in a previously performed 
statewide prevalence study in Utah (Wilson et al., 2009).  During the follow-up portion of 
that study, Dairy 1 experienced an outbreak of clinical mastitis (CM) caused by 
Mycoplasma spp. which was associated with the isolation of Mycoplasma spp., of which 
2 isolates were found by PCR to be M. bovis, from bedding sand and piles of recycled 
bedding sand that was designated to be reused.  Dairy 1 had approximately 4,500 milking 
cows housed on dry lots and freestalls bedded with recycled sand.  The endemic rate of 
CM attributable to Mycoplasma spp. was approximately 3 cases/4,500 cows per month.  
During the outbreak, aseptic milk samples from all CM cases were cultured from this 
herd by the herd health veterinarians (RH and RC).  During the CM outbreak, the rate of 
mycoplasma mastitis cases increased to approximately 35 cases/4,500 cows per month. 
At this dairy, the bedding sand is recycled by scraping it out of the alleys, into a flume 
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where the manure is washed free.  This is followed by a second washing step on a cement 
pad with a low slope.  After drying, the sand is swept up and stored for several months in 
large, elongated piles (approximately 3.75 m tall and 3.75 m wide by 600 m long) prior to 
reuse.  Samples of bedding sand from freestalls and the piles of recycled sand were 
collected by the herd health veterinarians. Composite bedding sand samples were 
collected from 20 freestall housing pens by collecting approximately 3 grams from the 
back third of every 10th stall.  Samples were identified by date and either the pen number 
or pile (letter designation).  Dairy 1 began using sand as the only bedding substrate in 
2001.  In 2004 the dairy began using recycled bedding in all pens and no new sand was 
imported with the exception of 1 month at the end of the described CM outbreak.  
Dairies 2 through 8 also had Mycoplasma spp. detected in bulk tank milk as part 
of the prevalence study (Wilson et al., 2009).  Composite bedding samples were collected 
(by DW and AJA) from the freestalls of those dairies by collecting approximately 3 
grams of material from the back third of 6 to 10 stalls per pen.  From hospital pens, 1 
sample was collected from each of 6 different areas of the pen.  Samples were identified 
with the dairy number, date, and pen number.  Conventional mycoplasma culture 
methods identified Mycoplasma spp. in the freestall bedding sand and recycled sand.  
PCR was used to determine whether or not the organisms isolated were M. bovis in 4 
samples from Dairy 1.  The protocols for each method are described below. 
Study Pile of Recycled Bedding Sand 
Mycoplasma spp.-positive recycled bedding sand (18,000 kg) was transported 
from Dairy 1 to Utah State University (USU) and stored in a pile (approximately 3 m in 
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diameter and 2 m tall) outdoors, uncovered on a hard asphalt surface away from animals 
or their waste.  The outbreak of mycoplasma mastitis at the dairy was resolving when the 
sand was removed from the dairy. The sand pile was composite sampled on the surface 
(from approximately 0 to 2 cm into the pile) and deep (from approximately 15 to 18 cm 
into the pile) layers on a weekly basis for 4 mo, from the beginning of April to the 
beginning of August.  Each composite sample was collected with a disposable spoon and 
consisted of subsamples containing ½ of a spoonful from each of 5 sites within the pile.  
After 3, 4, and 5 ½ mo of study, single site samples were taken from very deep 
(approximately 50 cm) in the pile.  For each sampling, surface and deep, a new plastic 
spoon was used.  The superficial sand that was removed from the deep sites was replaced 
in the sampling site after the sample was removed.  Previously sampled sites were easily 
identified and a new set of sampling sites were used for each collection.  The temperature 
of the pile at the surface (2 cm) and deep (18 cm) locations was measured with a standard 
digital soil thermometer on each sampling day at 1600 h. 
  After 4 mo, the pile was composite sampled every 14 to 28 d for the next 2 mo 
(August to October).  After 6 mo (the beginning of October), the sand was moved by a 
construction crew seeking access to a job site; most of the sand was stored in a dump 
truck bed and some was taken to a nearby storage site away from animals or their waste, 
and then the sand was returned after 24 h.  The sand was moved again approximately 3 
wk later (October 28), when it was relocated to another outdoor site where it was stored 
uncovered, on cement, for use in another study.  Weekly sampling resumed and 
continued for 7 wk.   
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Temperature and Precipitation Records 
for Logan Utah 
Weather data (daily highs and lows, and daily precipitation in inches) were 
obtained from the USU Utah Climate Center for the weather station closest to the sand 
pile (lat. 41°44'26", long.-111°48'37", elev. 1,460 m). This weather station is less than 3.2 
km from the storage sites of the sand pile.  
Sand Composition Testing 
Sand nitrogen and carbon content were determined by the Utah State University 
Analytical lab (USUAL).  A composite sample of approximately 1 kg of sand was 
collected from the recycled bedding sand pile 1 mo after the sand arrived at USU.  
Additionally, a sample of unused sand from the source sand pit and composite samples of 
stored recycled bedding sand from Dairy 1 were tested for total nitrogen, total carbon, 
and organic content. 
Bedding Culture: from Dairies and from 
the Pile of Recycled Bedding Sand 
Bedding samples were collected into new ziplock plastic bags.  When freestalls 
were being sampled, 6 to 10 stalls were sampled from each pen; samples were taken from 
the back third of every tenth stall.  Samples were held at 4 °C and shipped within 24 h in 
padded envelopes to The Dairy Authority Laboratory (TDA, Greeley, Colorado) by 
priority mail (2 d delivery).  Samples were cultured using 1 g of bedding diluted in 
1,000 ml of sterile water to make an initial 1,000 fold dilution. Three additional 1:10 






 dilutions. For all dilutions, 50 µl of 
sample was plated and counted to determine colony forming units (cfu/g).  Aerobic 
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culture was performed using MacConkey, modified Edward’s agar (A70, Hardy 
Diagnostics, Santa Maria, CA), and Mannitol Salt agars for 48 h at 37 °C.   Plates were 
examined at 24 and 48 h and the growth recorded.  Mycoplasma culture was performed 
on modified Hayflick medium (G102, Hardy Diagnostics) using the same dilutions with 
10% CO2 and 80% humidity for 10 d.  Plates were examined at 3, 7, and 10 d under 2X 
magnification with confirmation at 4X magnification and the colonies morphologically 
consistent with Mycoplasma spp. were counted.  Mycoplasma plates that were overgrown 
with other types of bacteria were defined as contaminated. 
Controlled Experiments with Recycled 
Bedding Sand 
Temperature Trials.  Bedding samples were collected from deep in the pile and 
incubated at -20 °C, 4 °C,  20 °C, 36 °C, and 60 °C in closed but not sealed petri dishes 
for 24, 48, and 72 h.  At 36 °C an additional trial was run by adding 250 µl of water at 24 
and 48 h of incubation in order keep the sample hydrated.  An additional trial consisted of 
prolonged incubation for 117 d at 4 °C of 4 recycled bedding sand samples (Samples A, 
B, C, and D) from Dairy 1.  After incubation for the allotted time, the samples were sent 
overnight to TDA on frozen cold packs for mycoplasma culture and cfu/g determination 
as described above.  Mycoplasma spp. cfu/g were compared to those from the same 
samples prior to incubation.  
Chemical Disinfection.  A large sample was collected from deep in the pile after 
2 mo and held at 4 °C for 3 d.  Sample fractions (2 g) of the sand were placed in 14 ml 
conical tubes, and mixed with 1 of the following: 4 ml of 2% chlorhexidine gluconate 
solution (Durvet, Blue Springs, MO); 0.5% chlorhexidine gluconate (1:4 dilution of 2% 
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solution); 1:10 dilution of household bleach (Clorox, Oakland CA), 0.5% sodium 
hypochlorite; or 1:30 dilution of household bleach (Clorox), 0.17% sodium hypochlorite.   
Sterile, deionized sterile water was used as a control.   The sand and disinfectant mixtures 
were allowed to stand undisturbed for 30 min at room temperature.  The chlorhexidine or 
sodium hypochlorite was removed by decanting the liquid, adding 8 ml of sterile 
deionized water, mixing, settling and decanting of the liquid.  The washing procedure 
was repeated 3 times.  The treated samples (those treated with disinfectant) and the 
control samples were shipped on frozen cold packs to TDA for mycoplasma culture and 
cfu/g of sample determination. 
Conventional PCR Protocol 
Sample Preparation.  Sample preparation, DNA extraction, PCR and post-PCR 
processing were performed at the UVDL.  Two 1 g volumes of bedding sand were 
washed with phosphate buffered saline (PBS) and the supernatant collected.  
Additionally, two 100 mg volumes were placed in 5 ml of PPLO broth and incubated for 
24-48 hours at 37 °C in 8% CO2.    
DNA extraction.  DNA was extracted from 150 µl PPLO broth culture and from 
the PBS wash solution with a commercial extraction kit for tissues and fluids (Qiagen, 
Valencia, CA).  Following the manufacturer’s protocol, briefly, the sample was mixed 
with 180 µl of tissue lysis buffer and 20 µl of proteinase K (Qiagen, Valencia, CA) and 
incubated at 55 °C for 2 h.  After incubation, 200 µl of AL (Qiagen, Valencia, CA) buffer 
were added and the mixture was incubated for 10 min at 70 °C.  After the addition of 200 
µl of ethanol, the mixture was transferred to the DNA binding spin column. The column 
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was sequentially washed with 500 µl of each of the wash buffers (Qiagen, Valencia, CA) 
and centrifuged at 5.9 X g for 1 min.  Finally, the DNA was eluted from the column by 
the addition of 100 µl of AE (Qiagen, Valencia, CA) buffer and centrifugation. Elution 
was performed twice. 
Conventional PCR.  Two conventional PCR protocols were used to detect 
Mycoplasma spp. or M. bovis DNA in the extracted DNA (L. Li, Alabama State 
Veterinary Diagnostic Laboratory, Auburn, Alabama, personal communication).  The M. 
bovis specific PCR master mix consisted of 35 µl of RNase free water, 5 µl of 10X PCR 
reaction buffer (Invitrogen, Carlsbad, CA), 1.5 µl MgCl2 (50 mM), 1.0 µl dNTP (10 
mM), 1 µl each of the forward and reverse primers (10 pmol/µl), and 2 U of Platinum 
Taq (Invitrogen).  The forward M. bovis specific primer (MYCO 5, Eurofins MWG 
Operon, Huntsville, AL) sequence was 5’ TGATAGCAATATCATAGCGGC 3’  and the 
reverse primer (MYCO 6, Eurofins MWG Operon, Huntsville, AL) sequence was 5’ 
GTAGCATCATTTCCTATGCTAC 3’.  The PCR reaction mix consisted of 45 µl of the 
PCR master mix and 5 µl of extracted DNA and produced a 400 to 420 bp amplicon 
when M. bovis was detected.  Each PCR assay included a positive M. bovis DNA control 
(M. bovis, ATCC # 25025) and a DNA-negative control (PCR grade water).  The PCR 
was performed using a conventional thermocycler (Eppendorf Gradient MasterCycler, 
Westbury, NY).  Cycling conditions for PCR included an initial denaturing step of 95 °C 
for 5 min, followed by 40 cycles of 95 °C for 30 s, 55 °C for 30 s, and 72 °C for 30 s, 
followed by a final step extension step of 72 °C for 5 min.  PCR products were analyzed 
with a capillary electrophoresis platform (2100 Bioanalyzer, Agilent, Santa Clara, CA) or 
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by standard electrophoresis with a 2% agarose gel run at 100 V for 1 h and 20 min for the 
identification of a PCR amplicon of equal size to the M. bovis positive control.   
The Mycoplasma spp. PCR protocol was a nested procedure.  The flanking 
reaction used a forward primer, MYCP 1 (5’ ACACCATGGGAGCTGGTAAT 3’, 
Eurofins MWG Operon, Huntsville, AL) and a reverse primer MYCP 2 (5’ CTT 
CATCGACTTTCAGACCCAAGGCAT 3’, Eurofins MWG Operon, Huntsville, AL) 
with the same PCR master mix as in the M. bovis specific protocol.  Each PCR reaction 
consisted of 5 µl of sample and 45 µl of master mix.  The thermocycling conditions were 
as follows:  94 °C for 45 s, 29 cycles of 94 °C for 30 s, 55 °C for 2 min, and 72 °C for 1 
min, finishing with 72 °C for 5 min and then a 4 °C hold.  The nested reaction used the 
forward nested primer, MYCO3, (5’ GTTCTTTGAAACTGAAT 3’, Eurofins MWG 
Operon, Huntsville, AL) and the reverse nested primer MYCO 4 (5’ GCATCCACC 
AAAAACTCT 3’, Eurofins MWG Operon, Huntsville, AL).  The PCR master mix for 
the nested protocol was 37.5 µl of RNase free water, 5 µl of 10X PCR reaction buffer 
(Invitrogen, Carlsbad, CA), 1.5 µl MgCl2 (50 mM), 0.5 µl dNTP (10 mM), 2 µl forward 
and reverse primer (20 pmol/µl) and 2 U of Platinum Taq (Invitrogen).  Each nested PCR 
reaction consisted of 49 µl of master mix and 1 µl of the flanking reaction product.  The 
thermocycling conditions for this reaction were 94 °C for 45 s, then 33 cycles of the 
following sequence: 94 °C for 30 s, 55 °C for 2 min, and 72 °C; the final step of 72 °C 
for 5 min was followed by a 4 °C hold.  Positive and negative controls were included as 
described above.  The PCR products were analyzed in the manner described above for the 
M. bovis specific reaction. 
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Results 
Culture of Bedding from Study Dairies 
Results of microbial culture of Mycoplasma spp. in bedding sand samples from 
the mycoplasma-positive Dairies 1 through 8 are summarized in Table 3.1.  Bedding sand 
from freestalls of 3 dairies, 1, 3 and 8, cultured positive for Mycoplasma spp. in 20 of 39 
samples, 1 of 3 samples, and 6 of 6 samples, respectively (Table 3.1).  Of the 2 samples 
of recycled bedding sand and the 2 samples of freestall bedding from Dairy 1 tested with 
PCR, the presence of Mycoplasma spp. was verified in 2 of the recycled sand samples 
and 1 of the freestall bedding samples.  Mycoplasma bovis was verified by PCR in 1 sand 
sample from freestall pens and 1 sample of recycled sand. The fourth sample was 
identified as positive for Mycoplasma spp. by microbial culture but the PCR results were 
inconclusive.  Except for the identification of Mycoplasma spp. in the straw bedding of 
pen 19 of Dairy 8, all of the positive samples were sand or dirt bedding.  Mycoplasma 
spp. cfu/g were not determined for Dairy 1. The Mycoplasma spp. cfu/g for all other 
dairies ranged from 1.2 X 10
3
 to 5.6 X 10
5
. 
Dairy 1 Sand Pile Culture Results and 
Association with Temperature and 
Rainfall 
Mycoplasma spp. Culture Results.  Results of microbial culture for Mycoplasma 
spp. in samples from the pile of recycled bedding sand collected from Dairy 1 following 
an outbreak of clinical mycoplasma mastitis are summarized in Table 3.2.  At the outset 
of the study, both the surface and deep samples were culture-positive with 7.7 X  10
5
 
cfu/g and 2.13 X 10
6
 cfu/g of sand, respectively (Table 3.2). The concentration of  
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Table 3.1:  Detection of Mycoplasma spp. in bedding sand from 8 Utah dairies with 
mycoplasma-positive bulk tanks 
 
Date Dairy Counts cfu/g Bedding type 
12/2007 Dairy 1 positive1 sand 
3/2008 Dairy 1 14/20 pens  positive1 sand 
6/19/2008 Dairy 2  neg. sand 
7/3/2008 Dairy 3 hospital  neg. sand 
7/3/2008 Dairy 3 pen 2 1,200 sand 
7/3/2008 Dairy 4  neg. straw 
7/3/2008 Dairy 5  neg. dried manure 
7/3/2008 Dairy 6  neg. straw 
7/3/2008 Dairy 7  neg. straw 
7/3/2008 Dairy 8 pen 3 72,000 sand 
8/20/2008 Dairy 1 pile A 8,000 sand 
8/20/2008 Dairy 1pile B 8,000 sand 
8/20/2008 Dairy 1 pile C neg. sand 
8/20/2008 Dairy 1 pile D neg. sand 
10/18/2008 Dairy 3 hospital neg. sand 
10/18/2008 Dairy 3 pen 2 neg. sand 
10/18/2008 Dairy 1 pile E, deep 34,200 sand 
10/18/2008 




Dairy 1, 4 piles, 4 
deep5
 neg. sand 
10/21/2008 Dairy 8 pen 1 560,000 sand 
10/21/2008 Dairy 8 pen 2 4,200 sand 
10/21/2008 Dairy 8 pen 12 30,000 sand 
10/21/2008 Dairy 8 pen 15 5,600 sand 
10/21/2008 Dairy 8 pen 19 6,000 straw 
1
cfu/g were not reported 
2
Piles E, F, G, H, I 
3
Superficial samples were taken from the surface to a depth of 0 to 1 cm 
4
Piles F, G, H, I 
5
Deep samples were taken from a depth of 15 to 18 cm 
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Table 3.2: Mycoplasma spp. (cfu/g) recovered from recycled bedding sand pile and 
ambient maximum temperature  
Date Deep Surface Tmax °C1
 
3/29/2008 2,130,000 770,000 9.4 
4/6/2008 990,000 720,000 6.1 
4/11/2008 420,000 neg. 6.7 
4/15/2008 182,000 neg. 23.3 
4/29/2008 2,000 neg. 22.2 
5/6/2008 68,000 neg. 23.3 
5/13/2008 47,600 neg. 11.1 
5/20/2008 3,400 neg. 28.9 
5/27/2008 2,200 neg. 12.2 
6/3/2008 7,800 neg. 23.3 
6/11/2008 60,000 neg. 12.2 
6/17/2008 4,000 neg. 30.0 
6/19/2008 16,800 neg. 28.9 
6/30/2008 2,000 neg. 33.3 
7/8/2008 33,400 neg. 30.0 
7/15/2008 neg. neg. 30.6 
7/22/2008 600 neg. 26.1 
7/30/2008 neg. neg. 33.9 
8/5/2008 neg. neg. 33.3 
8/20/2008 neg. neg. 31.7 
9/25/2008 neg. NR 25 
10/6/2008 Sand pile moved and replaced  
10/10/2008 14,200 1,000 14.4 
10/28/2008 Sand moved to calf facility  
10/30/2008 1,400 neg. 20.6 
11/6/2008 32,000 neg. 3.9 
11/12/2008 600 neg. 8.3 
11/20/2008 200 neg. 11.1 
11/28/2008 neg. neg. 11.1 
12/3/2008 neg. neg. NR2 
12/11/2008 neg. neg. NR 
12/17/2008 3,000 neg. NR 
1
Tmax. is the maximum ambient temperature in °C.  
2
NR is not recorded. 
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mycoplasmas in surface samples of the recycled sand pile rapidly declined and the 
surface became mycoplasma culture-negative after 3 wk (Table 3.2).  The samples from 
the deep portions of the pile became culture-negative on July 30, 2008 following apparent 
cyclic replication of Mycoplasma spp. deep within the pile as evidenced by temporal 
fluctuations in cfu/g recovered from the pile that corresponded to changes in temperature 
and precipitation.  Recovery of Mycoplasma spp. from the sand pile appeared to be 
dependent on ambient temperature (Table 3.2).  Not included in the table is a sample 
taken on July 8th from the very deep (50 cm) layer of the pile. This sample was positive 
at 60,000 cfu/g.  Subsequent samples from this depth on August 5th and September 25th 
(also not included in the table) were negative. 
Several factors including ambient and sand pile temperatures, precipitation and 
growth of other microorganisms in the pile were investigated to determine their role in 
persistence and replication of Mycoplasma spp. within the pile of recycled bedding sand.  
Figure 3.1 is a graphical representation of the temperature changes within deep portions 
of the sand pile compared to the ambient maximum temperature over the duration of the 
study.  Initially, the entire pile was visibly and palpably damp; as the spring and summer 
progressed, the surface became dry and crusted but the deep interior remained moist even 
when the deep samples collected were culture-negative for mycoplasma.  
Figure 3.2 demonstrates the association of recovery of Mycoplasma spp. with 
temperature within the pile and precipitation.  Initially, recovery of Mycoplasma spp. in 
the pile declined quickly which was followed by increasing and decreasing isolation of  
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Figure 3.1:  Temperature (°C) of the bedding sand at the deep level (T deep pile) 
compared to the ambient temperature (Tmax) of USU, Logan, Utah.  
mycoplasma until the pile temperature stabilized at approximately 30 °C and measurable 
precipitation ceased.   Mycoplasma spp. cfu/g increased 30-fold (from 2.0 X 10
3
 to 6.0 X 
10
4
 cfu/g) and then decreased 3 times between May and July. With the first 2 spikes in 
Mycoplasma spp. cfu/g recovered from the pile, the pile temperature was between  
15 °C and 20 °C and there were recorded events of moderate precipitation.  However, the 
last spike in Mycoplasma spp. concentration recovered from the pile during early summer 
was not associated with a recorded precipitation event and temperature in the pile was 
nearly 30 °C.  Following this last spike in replication of Mycoplasma spp., the 
concentration of mycoplasma within the pile rapidly declined as the temperature of the 
pile reached greater than 30 °C and this high temperature persisted. During the summer 
mycoplasmas were not recovered from the pile via culture.  Measurable Mycoplasma spp. 
growth within the pile reoccurred when pile temperature decreased to 14 °C and 
coincided with 2 of the largest precipitation events during the study.  Precipitation 
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Figure 3.2:  Recovery of Mycoplasma spp. within the recycled bedding sand pile and the 
cyclic growth of Mycoplasma spp. as it relates to precipitation and temperature. Cfu/g are 
reported as actual values x 10
-3
, Deep temperature = T °C, and precipitation is reported in 
inches x 10
2
.  Asterisks indicate when the pile was moved (Oct. 7 and Oct. 28). 
on Oct. 5 was followed by movement of the pile, the contents were rearranged and mixed 
and subsequent samples collected were culture positive for Mycoplasma spp.  
(1.4 X 10
4
 cfu/g initially deep within the pile), even though weekly samples during the 6 
previous wk were culture negative (Figure 3.2).  When the pile was moved a second time 
to another outdoor location, there was an additional 20-fold increase in cfu/g (from  
1.4 X 10
3
 to 3.2 X 10
4
 cfu/g) of Mycoplasma spp. recovered from the deep layer of the 
pile which occurred 8 d following this movement.   
 
   
86
Results demonstrate a positive association with precipitation and pile movement 
and increased replication and recovery of Mycoplasma spp. from the pile of recycled 
bedding sand, while demonstrating a negative association between recovery of 
Mycoplasma spp. and ambient temperatures.  After 6 wk of no recovery of Mycoplasma 
spp. from the pile, Mycoplasma spp. could be recovered from the pile after the favorable 
temperature and moisture conditions returned. Results indicate that there was long-term 
survival of Mycoplasma spp. in the most protected strata of the recycled bedding sand, 
even during periods when none could be isolated by microbial culture of the more 
superficial strata.   
Aerobic Culture Results.  Figures 3.3 and 3.4 provide a comparison of growth 
patterns of Mycoplasma spp. to growth patterns of Gram-negative microorganisms and 
Streptococcus spp. within the pile of recycled bedding sand over the duration of the  
 
Figure 3.3:  Association of the growth of Mycoplasma spp. and Gram-negative 
microorganisms in recycled bedding sand. Cfu/g are reported as actual values x10
-3
. 
Asterisks indicate when the pile was moved (Oct. 7 and Oct. 28). 
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study.  The Gram-negative microorganisms consisted primarily of Pseudomonas spp., 
and the reported cfu/g ranged from 6.8 X 10
5
 in the deep layer of the bedding pile early in 
the year to undetectable in early August. Growth of Gram-negative microorganisms 
within the pile preceded (2 events) or coincided (3 events) with rises in Mycoplasma spp. 
cfu/g, but occurred at higher magnitude (Figure 3.3).  Streptococcus spp. cfu/g ranged 
from 2.2 X 10
5
 to undetectable with the highest counts occurring early in the year and in 
July. The growth of Streptococcus spp. within the preceded the growth of Mycoplasma 
spp. once and coincided with an increase in Mycoplasma spp. twice (Figure 3.4). 
Sand Composition 
The total nitrogen content was 0.03% and the total carbon content was 1.33% for 
the recycled bedding sand pile.  The nitrogen and carbon contents are consistent with the 
presence of organic matter (Godden et al., 2008) which may play a role in biofilm 
 
Figure 3.4:  Growth patterns of Mycoplasma spp. and Streptococcus spp. in recycled 
bedding sand.  Cfu/g are reported as actual values x10
-3
. Asterisks indicate when the pile 
was moved (Oct. 7 and Oct. 28). 
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formation in recycled bedding sand.  The unused bedding sand had a total nitrogen 
content of 0.01% and a total carbon content of 1.48%.  The amount of organic material in 
the unused bedding sand was 0.1%.  Samples of recycled bedding sand taken from the 
stored piles at the dairy had a mean organic content of 2.1%, mean nitrogen content of 
0.185% and mean carbon content of 1.23%. 
Temperature and Prolonged 
Refrigeration Effects on Mycoplasma spp. 
Growth and Survival 
The controlled temperature experiments were conducted to obtain more data 
relative to survival and optimal growth temperatures for Mycoplasma spp. in recycled 
bedding sand.  Results of these experiments are provided in Tables 3.3 and 3.4.  
Mycoplasma spp. survived for 24 h at all controlled temperatures tested except 60 °C 
(Table 3.3).  For the short term experiments, the highest percent survival rate occurred at 
20 °C with 32.5% mycoplasma viable after 48 h and 9.1% mycoplasma viable after 72 h.  
At 36 °C, the Mycoplasma spp. remained viable as long as the sand was kept damp 
Table 3.3:  Percent survival of Mycoplasma spp. at controlled constant temperatures in 
recycled bedding sand. Results are expressed as percent survival which was calculated as 
the number of organisms at time x divided by the number of organisms at time 0; ND—
not done 
Time -20 °C 4 °C 20 °C 36 °C 
36 °C 1 
w/H20 
60 °C 
24 h. 12.6 67.0 55.0 100 ND neg. 
48 h. 6.7 6.7 32.5 neg. 7.2 neg. 
72 h. 2.5 4.8 9.1 neg. 37.5 neg. 
1
250 µl of deionized tap water was added at 24, 48, and 72 hours of incubation 
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by adding 250 µl of water every 24 h. After 72 h the cfu/g of Mycoplasma spp. in sand 
increased to 24,000 cfu/g from 4,600 cfu/g at 48 h, indicating possible replication at  
36 °C. 
 A prolonged refrigeration (4 °C) survival experiment was carried out by storing 3 
kg samples (n = 4) collected from Dairy 1 for 117 d, moist, in sealed ziplock bags (Table 
3.4). Following prolonged incubation at 4 °C, Mycoplasma spp. increased from 8,000 
cfu/g to a mean 131,000 cfu/g in 2 of the 4 samples; the other 2 samples remained 
negative.  Replication of mycoplasma in recycled bedding sand occurred at temperatures 
from 4 °C to 36 °C in the laboratory setting.  These data are consistent with the effects of 
ambient temperature and temperature deep within the sand pile on Mycoplasma spp. 
growth patterns observed in the pile of recycled bedding sand that was kept outdoors.   
Chemical Disinfection Experiments 
   The continuing survival of the organisms in the pile of recycled sand suggested 
that an environmental source for Mycoplasma spp. could be established; we conducted 
experiments to evaluate the efficacy of 2 disinfectants in the reduction or elimination of 
mycoplasma in recycled bedding sand.  Bleach (sodium hypochlorite) and chlorhexidine 
Table 3.4:  Recovery of Mycoplasma spp. following prolonged refrigeration of bedding 
sand from Dairy 1. Initial cfu/g: collection date 8/20/08; Ending cfu/g: collection date 
12/17/08. 
Source pile Initial cfu/g Ending cfu/g 
Dairy 1 pile A 8,000 200,000 
Dairy 1 pile B 8,000 62,000 
Dairy 1 pile C neg. neg. 
Dairy 1 pile D neg. neg. 
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gluconate were chosen on the basis of availability, use in the dairy industry, and for 
bleach, low cost.  These 2 disinfectants were tested at 2 different concentrations.  After 
incubation with the disinfectant, the sand was washed 3 times with deionized sterile water 
to reduce the disinfectant residue and to reduce inhibition of bacterial growth. Bedding 
sand treated with sterile water served as a control for these experiments.     
The number of viable (cultivable) Mycoplasma spp. in recycled bedding sand was 
reduced in all treatment groups (Table 3.5).  Treatment of contaminated sand with 0.5% 
chlorhexidine or 0.17% sodium hypochlorite resulted in 97.3% and 93.3% reductions in 
colony counts of Mycoplasma spp., respectively. Treatment with higher concentrations of 
disinfectants, 2% chlorhexidine and 0.5% sodium hypochlorite, resulted in 100%  
Table 3.5: Concentration dependent efficacy of 2 common chemical disinfectants in 
reduction of Mycoplasma spp. in contaminated recycled bedding sand.  Data represent the 
mean of 2 replicates. Calculated percent reduction of Mycoplasma spp. as compared to 





















2,200  neg. 33,000  
percent 
reduction 
97.3% 100% 93.3% 100% 0% 
1
Colony forming units 
2
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reduction of mycoplasma colony counts from contaminated bedding sand – none could be 
isolated by culture.  Results demonstrate the initial efficacy of 2 common disinfectants in 
reducing Mycoplasma spp. in contaminated recycled bedding sand.  
Discussion 
Classically, recognized modes of transmission of mycoplasma associated disease 
in dairy cattle include direct cow to cow transmission by inhalation and respiratory 
secretions and through contaminated milking equipment (Jasper, 1977; González and 
Wilson, 2003; Nicholas and Ayling, 2003).  Others have found mycoplasma pathogens in 
cooling ponds and dry lots in association with mycoplasma disease in dairy herds but the 
clinical significance of these environmental sources of this infectious agent remains 
undetermined (Bray et al., 1997; González and Wilson, 2003).  Previous laboratory 
studies reported that M. bovis survived up to 236 d in manure and 23 d in drinking water 
at 23 °C to 28 °C (González and Wilson, 2003).  The finding of multiple Mycoplasma 
spp.-positive bedding samples associated with an outbreak of Mycoplasma spp. mastitis 
initiated the investigation reported here into the survival of mycoplasma in recycled 
bedding sand and factors associated with the persistence of this possible environmental 
source of Mycoplasma spp.  Previous studies demonstrated that exposure of the teat ends 
to microorganisms in bedding can result in the development of mastitis (Kristula et al., 
2005; Godden et al., 2008).  The amount of mycoplasma organisms required to induce 
mastitis is not well defined but researchers have successfully induced mastitis by direct 
teat infusion of 70 cfu of M. bovis (Bennet and Jasper, 1980). In this study the amounts of 
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suggesting that this environmental source may play a role in the epidemiology of 
mycoplasma-associated disease.   
Moreover, the present results showed that Mycoplasma spp. remained viable in 
recycled bedding sand intermittently over a prolonged period of time (8 mo), and that the 
concentration of mycoplasma in the sand was associated with temperature, precipitation 
(moisture), and possibly, the growth of Gram-negative microorganisms within the pile.  
There was renewed isolation of Mycoplasma spp. in the pile of recycled bedding sand 
after it had been repeatedly culture-negative for some time.  This new isolation of 
mycoplasma occurred following the return of favorable growth conditions and movement 
of the pile.  Utilization of a pooled sampling method should have minimized the 
variability in the counts due to location within the pile, so that increases of at least 10-
fold can be interpreted as true increases in the numbers of organisms per gram.  In 
addition, the smaller samples that were stored at 4 °C and 36 °C also demonstrated 
similar increases.  Therefore, it is likely that there was indeed growth of mycoplasma 
after the sand pile was moved and conditions were more favorable for growth.  A 
previous study of aerated and unaerated leachfield soil found that the active microbial 
population was 5 times higher in aerated soil (Amador et al., 2006).   
Mycoplasma spp. possess a unique combination of traits including: a genome that 
has undergone major reduction which includes loss of cell wall production, a resistance to 
some antibiotics as a result of the absence of a cell wall, reduced sensitivity to freezing 
but increased sensitivity to desiccation and chemical agents, and growth requirements for 
exogenous sources of sterols and lipids (Razin et al., 1998; González and Wilson, 2003; 
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Walker, 2004).  In our recycled sand pile study, we identified the occurrence of factors in 
recycled bedding sand over time that supported the establishment of an environmental 
source for Mycoplasma spp.  Factors included sand pile temperature, precipitation 
(moisture), and low levels of organic material.  Organic matter will support more 
bacterial growth than clean sand and recycled bedding sand contains a low level of 
organic material (Godden et al., 2008).  The variability of different bedding materials to 
support of growth microorganisms has been investigated (Kristula et al., 2005; LeJeune 
and Kauffman, 2005; Godden et al., 2008).  Depending on the recycling process and 
storage conditions, recycled bedding sand will vary in the amount and composition of 
organic material that will provide support for bacterial growth (Kristula et al., 2005).  
Given that isolation and growth of mycoplasmas in the laboratory requires 
complex media that include sterols, lipids and nucleotides, it is unlikely that low levels of 
nitrogen and organic compounds would support prolonged survival of mycoplasmas.  The 
formation of a biofilm community that included mycoplasmas and Gram-negative 
organisms could account for the survival and replication of mycoplasmas in what at first 
appears to be a growth factor deficient environment.  Biofilms are defined as a 
heterogeneous but highly organized community of microbial cells collected into 
microcolonies embedded in extracellular polymeric substance matrix (Donlan, 2002; 
Halverson, 2005).  In the cycle of replication and cell death, the other less fastidious 
organisms could supply the nutrients required by the mycoplasmas.  Sand has been 
previously demonstrated as a matrix for biofilm development for Escherichia coli 
(Landini and Zehnder, 2002) and Pseudomonas aeruginosa (Holden et al., 2002; Robleto 
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et al., 2003).  A previous study (McAuliffe et al., 2006) found that many strains of M. 
bovis were capable of forming biofilms and in a biofilm M. bovis was more resistant to 
desiccation and temperature extremes.  Our results support this observation and it may 
explain why Mycoplasma spp., including M. bovis can persist in a pile of recycled 
bedding sand over the hot, dry summer months.  
In this study, the ideal temperature for survival and growth of Mycoplasma spp. in 
recycled bedding sand ranged from 15 °C to 20 °C.  Mycoplasma spp. replicated in the 
sand at 4 °C when stored for 117 d and remained viable at temperature ranges from  
4 °C to 27 °C.  Our results are consistent with previous investigations of the survivability 
of M. pneumoniae (Wright et al., 1968). That study tested the viability of this organism in 
an aerosol at controlled temperatures; M. pneumoniae survived best at 15 °C.  Another 
study found that some species of mycoplasma, including M. bovis, M. bovirhinis, M. 
arginini, remained viable from 50 to more than 100 d in liquid media at 4 °C but only 
remained viable for 7 to 28 d at outdoor temperatures on paper discs (Nagatomo et al., 
2001).   
The present study demonstrated that Mycoplasma spp. occurred in high numbers 
in bedding sand from a dairy concurrently experiencing a clinical outbreak of 
mycoplasma mastitis and that an environmental source for Mycoplasma spp. can be 
established in recycled bedding sand. Therefore, we conducted experiments to evaluate 
the efficacy of 2 common disinfectants in the reduction or elimination of Mycoplasma 
spp. in recycled bedding sand.   Reportedly, the advantage of using sand as a bedding 
material is the potential to remove or inactivate most of the microbial contamination 
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through washing (Kristula et al., 2005; Godden et al., 2008); however, in our study, 
Mycoplasma spp., including some isolates confirmed by PCR as M. bovis, and other 
microorganisms could be recovered from washed (recycled) bedding sand.  Following 
treatment with 2% chlorhexidine and 0.5% sodium hypochlorite, no Mycoplasma spp. 
could be isolated from previously positive bedding sand, demonstrating the efficacy of 2 
common disinfectants in reducing or eliminating mycoplasma, or at least making it such 
that none could be isolated thereby reducing the potential for the transmission of disease.  
In summary, Mycoplasma spp. was discovered in high numbers in recycled 
bedding sand originating from a dairy experiencing an outbreak of clinical mycoplasma 
mastitis, and was also found in bedding from 2 other farms with mycoplasma-positive 
cows.  Mycoplasma spp. survived in recycled bedding sand for 8 months and replication 
was associated with temperature and precipitation.  Recycled bedding sand appeared to 
be an environmental source of Mycoplasma spp.  Results warrant investigation of the 
contribution of biofilm formation in the establishment of this environmental source and 
the epidemiological role of this source of mycoplasma-associated disease.  Chemical 
disinfection appeared to be effective, but practicality and cost-effectiveness require 
further study.  Moisture appears to contribute to the survival and replication of the 
organism in bedding sand.  This is also an avenue for further investigation because 1 
method of reducing the numbers of all bacteria in recycled bedding sand could be to 
improve drying by repeatedly turning the piles, at least in arid climates such as in the 
western United States.  
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CHAPTER 4 
SUMMARY AND CONCLUSIONS 
The first mycoplasma was identified as a disease agent by Nocard et al. in 1896 
when the field of microbiology was in its infancy.  Although the organism was too small 
to visualize with the optics of the day, they were able to determine that a biologic agent 
was the cause of contagious bovine pleuropneumonia, to culture it in a membranous 
pouch which resulted in broth solution becoming cloudy in appearance, and to use that 
culture solution to cause disease in a susceptible calf (Nocard et al., 1896).  The story of 
our developing understanding of mycoplasmas illustrates the development of scientific 
techniques, methods, and technological advancements: from utilizing chick embryo 
cultures to undefined media incorporating animal products to the use of PCR to detect the 
presence of mycoplasmas in tissues and fluids (Eaton et al., 1945; Brown et al., 1999; 
Bashiruddin et al., 2005); from the identification of the cell types involved in the 
pathologic processes to the identification of the cytokines produced in response to the 
presence of mycoplasmas (Howard et al., 1987; Razin et al., 1998; Vanden Bush and 
Rosenbusch 2003); from the classification of organisms based on morphology and 
disease syndrome to reclassification of hemoplasmas based on matching DNA sequences 
(Rikihisa et al., 1997).  Research of the basic biology of mycoplasmas has revealed that 
this group of organisms is both simple and complex.   
Many mycoplasmas cause similar disease syndromes and have a tropism for 
related tissues.  While some of the diseases are acute, such as contagious bovine 
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pleuropneumonia and contagious caprine pleuropneumonia, many more present with a 
chronic course which heavily impacts production parameters (Wallgren, 2004; Gaunson 
et al., 2006; Wilson et al., 2007).  Most of the diseases are characterized by 
lymphoproliferative infiltrates in the affected tissues which is in contrast to the 
polymorphonuclear response seen with many bacterial infections (Jasper et al., 1987; 
Brown et al., 1994; Paape et al., 2000).  Identification of mycoplasmas as the causative 
agent is often difficult, especially in the individual animal because many of the organisms 
grow slowly or have complex requirements for growth in culture (Thiacourt and Bölske, 
1996; González and Wilson, 2003).  Antibody tests are improving in both sensitivity and 
specificity but ultimately these tests rely on the animal response to disease which is 
highly variable because of the effects on the host immune system (Thiacourt and Bölske, 
1996; Wallgren, 2004).  Mycoplasmas have mechanisms to evade the host immune 
system through rapid variations in immunogenic proteins thus causing the production of 
an inconsistent antibody population.  By causing the host’s immune system to produce 
cytokines that affect the ratio of the T lymphocyte cell populations, they also affect the 
level of antibody production, the overall level of activation, and the effectiveness of the 
response (Razin et al., 1998).  Finally, many of the mycoplasmas share epitopes which 
makes separation of species with polyclonal antibodies difficult (DaMassa et al., 1992; 
Thiaucourt and Bölske, 1996).   
For many of the mycoplasma diseases, the organisms persist within the host, 
therefore diagnostic tests which identify the organism itself may be more reliable.  
Methods for antigen detection are usually either based on antibodies directed toward the 
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organism such as ELISA, or DNA based such as PCR.  Some new tests have been 
developed using MAb which have the benefit of being adaptable to field diagnostics 
(Thiacourt et al., 1994; Stipkovits and Kempf, 1996).  The literature suggests however 
that the methods that show real promise for specificity and sensitivity are PCR methods.  
Several techniques, such as restriction fragment length polymorphism and denaturing gel 
gradient electrophoresis, have been used to analyze the amplicon generated in order to 
determine the species, something that is often needed with mycoplasmas as the amplified 
genes are often highly conserved but vary in size (Foddai et al., 2005; McAuliffe et al., 
2005).  Another method used is to analyze the melt temperature, the temperature at which 
the double stranded DNA separates, of amplicons generated.  This real-time PCR method 
works by detecting the fluorescent marker which is released with the separation of the 
DNA.  This has been used to detect Mycoplasma spp. contamination of mammalian cell 
cultures (Ishikawa et al., 2006). 
Another problem associated with mycoplasma infections lies with development of 
effective vaccines.  An ideal vaccine stimulates an immune response that efficiently 
removes organisms from the host without damaging tissues.  Because of the 
immunomodulatory effect of many mycoplasmas including the production of 
upregulating cytokines, the risk of negative vaccine reactions is highly probable with 
whole cell bacterins and attenuated vaccines (Whithear, 1996; Kleven, 2008; Maunsell 
and Donovan, 2009).  Many attenuated mycoplasma vaccines have been developed by 
repeated passages in culture but reversion to virulence can occur as the vaccine strain 
circulates in the host population (Whithear, 1996; Kleven, 2008).  An additional 
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challenge to vaccine development is the phase and size variation of cell surface antigens 
that occurs in the population of organisms infecting a group of animals; this creates a 
moving target for the immune response.  As mycoplasma cell surface proteins have been 
identified, researchers have begun testing vaccines based on subunits as well as whole 
proteins.  Some of these have been effective experimentally such as the 1 developed for 
M. hyopneumoniae (Kobisch et al., 1987). 
For almost all mycoplasmal diseases, the source of infection has generally been 
recognized as chronically or latently infected carriers.   Documented routes of 
transmission include direct contact between animals, indirect contact via contaminated 
milking equipment and personnel, and for preweaned animals, the consumption of 
contaminated colostrum and milk.  Because mycoplasmas lack a cell wall which appears 
to increase susceptibility to drying, elevated environmental temperatures, and to some 
disinfectants, environmental contamination and exposure have not been considered 
significant factors in the disease process.  However, a number of researchers have 
documented experimental survival of pathogenic mycoplasmas on various substrates at 
temperatures ranging from 4 °C to 28 °C (González and Wilson, 2003).   
The original research in presented in this thesis describes the survival and 
replication of Mycoplasma species, confirmed with PCR as M. bovis in 2 samples, in 
recycled bedding sand.  The study began with the investigation of an outbreak of 
mycoplasma mastitis at a dairy farm in Utah.  It was discovered that recycled bedding 
sand used in freestalls was positive for M. bovis by microbial culture and conventional 
PCR.  In order to determine if the presence of M. bovis in the recycled bedding could 
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contribute to the persistence of mycoplasma mastitis at the dairy, 18,000 kg was moved 
to Utah State University and serially and quantitatively cultured for 8 mo.   
While there were times at which mycoplasma organisms could not be recovered 
from the pile, samples were intermittently culture positive over a period of 8 months.  
There were several factors that appeared to influence the number of mycoplasma 
organisms recovered.  The project started in the spring with an initial marked decline in 
the number of all types of organisms recovered from the deep sampling stratum (15 to 18 
cm from the surface).  As environmental temperatures climbed above 25 °C and the 
weather became drier, the number of mycoplasmas declined to 10
2
 organisms per gram of 
sand.  Two, one hundred-fold increases were seen during the early part of the summer 
and both coincided with moderate precipitation events.  As the weather cooled in the fall, 
Mycoplasma spp. were again recovered from the bedding pile. An additional factor 
appeared to play a role in this increase.  Serendipitously and due to factors beyond the 
control of the researchers, the recycled bedding sand was removed from the study site, 
temporarily stored in a dump truck and then replaced.  An additional precipitation event 
also occurred.  The result was that the number of mycoplasma organisms recovered 
increased from undetectable to greater than 10
4
 cfu/g of bedding.  This phenomenon 
recurred when the pile was purposefully moved by the researchers a month later.  These 
results suggest that a Mycoplasma spp. which was identified as M. bovis at the outset of 
the study was able to replicate in recycled bedding sand, an event previously considered 
unlikely based on the culture requirements of the organism. 
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Research has determined that Mycoplasma spp. and M. bovis in particular are 
capable of forming single species biofilms (a heterogeneous but highly organized 
community of microbial cells) in the laboratory (McAuliffe et al., 2006).  Sand has been 
previously demonstrated as a matrix for biofilm development for Escherichia coli 
(Landini and Zehnder, 2002) and Pseudomonas aeruginosa (Holden et al., 2002; Robleto 
et al., 2003).  Organisms within a biofilm are more resistant to desiccation, changes in 
temperature, and some disinfectants (McAuliffe et al., 2006).  While it is not clear from 
the results, there could be an interaction occurring between the Mycoplasma spp. and 
either the Gram-negative organisms, the Gram-positive organisms or both.  
The clinical significance of the recovery of M. bovis for 8 months in a pile of 
recycled bedding sand is uncertain.  Experimentally, mycoplasma mastitis can be caused 
with the infusion of as few as 70 cfu into the teat end (Bennet and Jasper, 1980).  
Previous studies have shown that exposure of the teat ends to microorganisms in bedding 
can result in the development of mastitis (Kristula et al., 2005; Godden et al., 2008).  The 





cfu/g, suggesting that this environmental source may play a role in the 
epidemiology of mycoplasma-associated disease.  Considered together, these points 
suggest that contaminated bedding sand could have a role in the perpetuation of a mastitis 
outbreak and with seasonal fluctuations in the number of organisms per gram of stored 
bedding, could even initiate an outbreak.  The results presented in this thesis suggest that 
research including investigation of biofilm formation by mycoplasmas and of 
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transmissibility of mycoplasma infections from environmental sources to ruminants 
including dairy cattle is warranted. 
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